Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
7 Westferry Circus ● Canary Wharf ● London E14 4HB ● United Kingdom Telephone +44 (0)20 7418 8400 Facsimile +44 (0)20 7418 8668 E-mail [email protected] Website www.ema.europa.eu
An agency of the European Union
© European Medicines Agency, 2011. Reproduction is authorised provided the source is acknowledged.
1 September 2011 EMA/721630/2011 Patient Health Protection
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004 Chapter 4: Structured substance information
Version 2.0
Date of coming into force: 1 September 2011
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 2/485
Table of Contents
4. Structured Substance Information ..........................................................3 4.1. Introduction.......................................................................................................3 4.1.1. Controlled Vocabularies ....................................................................................3 4.1.2. Naming Conventions ........................................................................................4 4.2. The Structured Substance Information Overview.....................................................4 4.2.1. The Structured Substance Information for Chemicals ............................................5 4.2.2. The Structured Substance Information for Proteins ...............................................6 4.2.3. The Structured Substance Information for Nucleic Acids ........................................7 4.2.4. The Structured Substance Information for Polymers..............................................8 4.2.5. The Structured Substance Information for Structurally Diverse Substances ..............9 4.2.6. The Structured Substance Information for Mixtures............................................. 10 4.2.7. The Structured Substance Information for Specified Substance Group 1................. 11 4.2.8. The Structured Substance Information for Specified Substance Group 2................. 12 4.2.9. The Structured Substance Information for Specified Substance Group 3................. 13 4.3. The Structured Substance Information Data Element Description............................. 14 4.3.1. SSI for Chemicals .......................................................................................... 14 4.3.2. SSI for Proteins ............................................................................................. 58 4.3.3. SSI for nucleic acids..................................................................................... 123 4.3.4. SSI for Polymers.......................................................................................... 182 4.3.5. SSI for Structurally Diverse Substances .......................................................... 256 4.3.6. SSI for Mixtures........................................................................................... 328 4.3.7. SSI for Specified Substance Group 1............................................................... 387 4.3.8. SSI for Specified Substance Group 2............................................................... 426 4.3.9. SSI for Specified Substance Group 3............................................................... 455
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 3/485
4. Structured Substance Information
4.1. Introduction
The Structured Substance Information (SSI) refers to the data elements that describe
detailed characteristics of the substance(s), which are ingredients of medicinal products.
An SSI file shall be created for each substance, which is an ingredient of a medicinal
product.
The SSI file shall be incorporated in the XEVPRM as outlined in chapter 3 published at
http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/docum
ent_listing_000336.jsp&murl=menus/regulations/regulations.jsp&mid=WC0b01ac0580410
138.
The set of characteristics that shall be provided in the SSI are based on the type of
substance class specified in the XEVPRM. The classification of the substance shall be based
on the principles outlined in the Annex published at
http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/docum
ent_listing_000336.jsp&murl=menus/regulations/regulations.jsp&mid=WC0b01ac0580410
138.
4.1.1. Controlled Vocabularies
The provision of certain information within the Structured Substance Information (SSI) is
based on the use of Controlled Vocabularies (CVs) and reference sources. The CVs to be
used are outlined in chapter 4.1. . For each data element where a CV applies, the name of
the CV that shall be used is described in the CV reference column in square brackets.
The CVs and the examples of reference sources are published at
http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/docum
ent_listing_000336.jsp&murl=menus/regulations/regulations.jsp&mid=WC0b01ac0580410
138
The CVs contain the following information:
List-name referring to the name of the CV, which is referenced throughout the
detailed guidance as applicable.
Term-ID referring to the unique identifier associated with each term of the CV.
Term-name (English) referring to the name of the controlled term in English.
Examples of Reference Sources are provided, where applicable.
Latin-name referring to the name of the controlled term in Latin, where applicable.
Synonym 1, 2 referring to the columns in the table that are repeated to describe
any other name or common name or synonym associated with the English term.
Description referring to the description of the term, where applicable.
The CVs will be regularly updated und new versions will be published at
http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/docum
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 4/485
ent_listing_000336.jsp&murl=menus/regulations/regulations.jsp&mid=WC0b01ac0580410
138.
4.1.2. Naming Conventions
The provision of substance and specified substance names within the XEVPRM and the SSI
relies on the use of various reference sources and conventions for the naming of
substances. Instructions on the naming conventions and examples of reference sources
are published at
http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/docum
ent_listing_000336.jsp&murl=menus/regulations/regulations.jsp&mid=WC0b01ac0580410
138.
4.2. The Structured Substance Information Overview
The characteristics to be defined for each substance class are specified in the chapters 4.1.
Depending on the nature of the substance, each substance shall be described based on the
3.
ned in chapter 4.3.5.
pecified Substance – Group 3 - characteristics are outlined in chapter 4.3.9.
following substance classes:
Chemical - characteristics are outlined in chapter 4.3.1.
Protein - characteristics are outlined in chapter 4.3.2.
Nucleic Acid - characteristics are outlined in chapter 4.3.
Polymer - characteristics are outlined in chapter 4.3.4.
Structurally Diverse Substance – characteristics are outli
Mixture - characteristics are outlined in chapter 4.3.6.
Specified Substance – Group 1 - characteristics are outlined in chapter 4.3.7.
Specified Substance – Group 2 - characteristics are outlined in chapter 4.3.8.
S
4.2.1. The Structured Substance Information for Chemicals
Figure 1 –Structured Substance Information (SSI) Chemical
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 5/485
4.2.2. The Structured Substance Information for Proteins
Figure 2 - Structured Substance Information (SSI) Protein
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 6/485
4.2.3. The Structured Substance Information for Nucleic Acids
Figure 3 -Structured Substance Information (SSI) Nucleic Acid
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 7/485
4.2.4. The Structured Substance Information for Polymers
Figure 4 - Structured Substance Information (SSI) Polymer
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 8/485
4.2.5. The Structured Substance Information for Structurally Diverse Substances
Figure 5 - Structured Substance Information (SSI) Structurally Diverse Substance
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 9/485
4.2.6. The Structured Substance Information for Mixtures
Figure 6 - Structured Substance Information (SSI) Mixture
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 10/485
4.2.7. The Structured Substance Information for Specified Substance Group 1
Figure 7 - Structured Substance Information (SSI) Specified Substance Group 1
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 11/485
4.2.8. The Structured Substance Information for Specified Substance Group 2
Figure 8 - Structured Substance Information (SSI) Specified Substance Group 2
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 12/485
4.2.9. The Structured Substance Information for Specified Substance Group 3
Figure 9 - Structured Substance Information (SSI) Specified Substance Group 3
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 13/485
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 14/485
4.3. The Structured Substance Information Data Element Description
4.3.1. SSI for Chemicals
For chemical substances the SSI shall be based on the following data elements:
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
substance
SUB
Language
SUB.LANG The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German
CV [Language]
Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology).
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 15/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
For the purpose of describing “Language”, “T” shall be used. In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered synonyms.
Substance_id
COM.1 The substance identifier shall be described based on a controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
CV [Substance Name]
N Alphanumeric
12
Substance_Clas
COM.2.CV Type of substance based on a controlled vocabulary.
CV
Y Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 16/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
sification
EXAMPLE: Single, Mixture
[Substance Class]
substance_name (1..n)
COM.SNM The substance name section This section contains the set of elements for the description of the name of the substance. The latest version of the Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.
Y
Substance_name
SNM.1 The name of the substance shall be specified.
Y Text 4000
Substance_name_type
SNM.2.CV The type of the name shall be specified based on a controlled vocabulary. EXAMPLE: Official name, Code
CV [Substance Name Type]
Y text 250
Language
SNM.3.CV The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes.
CV [Language]
Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 17/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: eng – English deu (T) - German
alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology). For the purpose of describing “Language”, “T” shall be used. In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered synonyms.
official_name (0..n)
SNM.ON The official name section N If “Official Name” has been specified in “Substance_Name_Type” this section is mandatory. For any other name type, the section is present as not mandatory.
Official_name_type
ON.1.CV The type of the official name shall be specified based on a controlled vocabulary.
CV [Source]
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 18/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: INN
Official_name_status
ON.2.CV The status of the official name shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed.
CV [Status]
Y text 250
Official_name_status_change_date
ON.3 The change date of the status of the official name shall be specified in line with the ISO 8601 date format, which shall be only entered when name is changed. EXAMPLE: 2011-06-01
ISO 8601 date format
N alphanumeric
10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD
official_name_domain (1..n)
ON.DOM Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have at least one “Official Name Domain”.
Official_name_domain
DOM.1.CV The domain of the name shall be provided based on a controlled vocabulary.
CV [Domain]
Y Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 19/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: Human Pharmaceutical
official_name_jurisdiction (1..n)
ON.JUR The jurisdiction of the official name section
Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have at least one “Official Name Jurisdiction”.
Official_name_jurisdiction
JUR.1.CV The jurisdiction of the official name shall be provided based on ISO 3166-1 alpha-2 codes with two exceptions: EL (not GR) is used to represent Greece, and UK (not GB) is used to represent the United Kingdom. For the European Union EU shall be used.
CV [Country Code]
Y Text 3
reference_source (1..n)
SNM.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be
Y
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 20/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
specified.
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE:
N/A N text 2500
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 21/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
substance_code (0..n)
COM.SC The substance code section This section describes the specific code(s) within one or more available code system(s) that apply to a substance.
N
Code SC.1 The specific code (the value) with regard to a referenced code system shall be provided. NOTE: InChI is not considered a code and shall be specified within the structure description.
N/A Y alphanumeric
500
Code_system
SC.2.CV The code system shall be specified based on a controlled vocabulary.
CV [Code System]
Y
Text 250
Code_system_id
SC.3.CV The identifier for the code system shall be provided based on a controlled vocabulary.
CV [Code System]
N alphanumeric
12
Code_sy SC.4.CV The status of the code system CV Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 22/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
stem_status
shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed.
[Status]
Code_system_change_date
SC.5 The change date of the code system shall be specified in line with the ISO 8601 date format, where applicable. EXAMPLE: 2011-06-01
ISO 8601 date format
N alphanumeric
10 This applies only when the code is changed, so it is not applicable for initial submission. ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD
Comment
SC.6 Any comment can be provided in this field, if necessary.
N Text 4000
reference_source (1..n)
SC.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be
Y
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 23/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
specified.
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE:
N/A N text 2500
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 24/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
version (1..n)
COM.VER The version section This section shall provide information on the version of the substance.
Y Where no “Version Number” and “Effective Date” have been assigned by an authority source, the version number shall be set as 0 with the date set as the date of initial submission of the substance.
Version_number
VER.1 The number of the version of the SSI shall be provided.
N/A Y numeric
4
Effective_date
VER.2 The date when the SSI was effective shall be provided in line with the ISO 8601 date format. This shall be defined when the SSI is generated or modified.
ISO 8601 date format
N alphanumeric
10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD
Change_made
VER.3 The description of the updates or changes of the SSI shall be specified.
N/A
N text 4000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 25/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
The field will be left empty when first insert of substance.
reference_information (1..1)
COM.RI The reference information section This section is used to provide details about: - substance classification - target - gene from which proteins are derived - substance relationship
Y
Comment
RI.1 Any comment can be provided in this field, if necessary.
N Text 4000
substance_classification (1..n)
RI.SCLF The substance classification
Y One or more “Substance Classifications” shall be specified.
Domain SCLF.1.CV The domain of the substance classification shall be provided based on a controlled vocabulary. EXAMPLE: Human Pharmaceuticals
CV [Domain]
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 26/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Substance_Classification
SCLF.2.CV Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture
CV [Substance Class]
Y Text 250 The information provided in this field shall be automatically populated based on the information provided in the Substance_Classification field (COM.2.CV).
Substance_classification_type
SCLF.3.CV The type of the substance shall be provided based on a controlled vocabulary. NOTE: When Substance_Classification=mixture and the substances that are forming the mixture are of the same class, the class of those substances shall be specified in this field. EXAMPLE: two chemicals forming the mixture, specified_classification_type = chemical If the substances that are forming the mixture are of a different class, the value ‘mixture’ shall be specified in this field.
CV [Substance Type] [Specified substance Type]
Y Text 250 When Substance_Classification= Single or mixture, the [Substance Type] CV applies. When Substance_Classification=Specified substance the [Specified Substance Type] CV applies.
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 27/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: One polymer combined in a protein, Specified_classification_type =mixture
Substance_classification_code
SCLF.4 The code of the classification type where applicable shall be specified based on a controlled vocabulary.
N alphanumeric
250
subtype (1..n)
SCLF.ST The subtype section Y
Substance_class_subtype
ST.1.CV The sub-type of the classification shall be described based on a controlled vocabulary. EXAMPLE: Vaccine, Herbal, Multiple Substances
CV [Substance subtype]
Y Text 250
reference_source (1..n)
SCLF.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 28/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference:
N/A N text 2500
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 29/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Encycl. 3: 429 (1792)
substance_relationship (0..n)
RI.REL The substance relationship This section shall provide information related to relationship of a substance, where this is applicable.
N
Relationship
REL.1.CV The relationship of a substance shall be defined based on a controlled vocabulary. NOTE: Target and gene elements are not to be specified in this section. EXAMPLE: transporter, metabolic enzyme
CV [relationship type]
Y Text 250
Interaction_type
REL.2.CV The type of interaction shall be specified based on a controlled vocabulary, where applicable. EXAMPLE: covalent
CV [Interaction Type]
N Text 250
Substance_id
REL.3 The substance identifier, for which the relationship is specified, shall be described.
CV [Substance Name]
N Alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 30/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
Substance_name
REL.4 The substance name shall be specified.
CV [Substance Name]
Y text 4000 Mandatory when there is a “substance relationship”
Amount_type
REL.5.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
amount (0..1)
REL.AMT The amount section N
Quantity Operator
AMT.1.CV CV [Quantity
N text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 31/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Operator]
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limi AMT.8 The higher limit value of the N Nume 10
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 32/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
t_numerator_value
substance shall be specified, where available.
ric
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 33/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
reference_source (1..n)
REL.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 34/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
gene (0..n)
RI.GN The gene section This section shall provide a
N This section does not apply when Substance_classification_type is
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 35/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
description of the gene in relation to a substance, where applicable. The gene section refers only to gene that is the origin of the substance (protein).
equal to chemical, Specified Substance Group 1, Specified Substance Group 2 and Specified substance group 3.
Gene_sequence_origin
GN.1.CV The common name for the organism from which the final gene sequence originated shall be specified based on a controlled vocabulary. NOTE: it applies primarily to proteins.
CV [Organism Name]
N Text 4000
Gene_id GN.2 The identifier of the gene shall be provided based on a controlled vocabulary. E.g.: YP_299723.1
CV [Gene Name]
N alphanumeric
12
Gene_name
GN.3 The complete name given for a gene shall be provided based on a controlled vocabulary. E.g.: hIL-10 gene
CV [Gene Name]
Y Text 4000
reference_ GN.RS The reference source section Y
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 36/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
source (1..n)
This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 37/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
Gene_element (0..n)
RI.GE The gene element section N
Gene_element_type
GE.1.CV The type of the gene element shall be specified based on a controlled vocabulary. EXAMPLE: enhancer, promoter, silencer, terminator
CV [Gene Element Type]
Y Text 250
Gene_element_id
GE.2 The unique identifier for the gene element shall be specified based on a controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID”
CV [Substance Name]
N Alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 38/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
Gene_element_name
GE.3 The specific gene element name shall be described based on a controlled vocabulary.
CV [Substance Name]
Y Text 4000
reference_source (1..n)
GE.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source
RS.2.CV The type of the reference source shall be specified based
CV
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 39/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
_type on a controlled vocabulary. EXAMPLE: INN
[Source]
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
Target (0..n)
RI.TRG The target section This section shall provide information on the target substance.
N This section does not apply when Substance_classification_type is equal to Specified Substance Group 1, Specified Substance
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 40/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
It refers for genes to the target of the protein expressed by that gene. For all the other substances type it refers to the substrate of the substance. EXAMPLE: enzyme, protein/channel, receptor
Group 2 and Specified substance group 3.
Target_gene_id
TRG.1 The identifier of the target gene shall be provided.
CV [Target Gene]
N alphanumeric
12
Target_gene_name
TRG.2 The target gene name shall be specified based on a controlled vocabulary. EXAMPLE: single substance, an enzyme type
CV [Target Gene]
Y Text 4000
Interaction_type
TRG.3.CV The type of interaction shall be specified based on a controlled vocabulary. EXAMPLE: Inhibition
CV [Target interaction type]
Y text 250
Target_o TRG.4.CV The type of target organism CV N Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 41/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
rganism_type
shall be specified based on a controlled vocabulary. EXAMPLE: human, viral
[Organism type]
Target_type
TRG.5.CV The target type shall be specified based on a controlled vocabulary. EXAMPLE: enzyme, receptor, membrane
CV [Target type]
N Text 250
reference_source (1..n)
TRG.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 42/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
Structure (0..n)
SING.STR The structure section The structure of the substance shall be described, where applicable
N The structure section is mandatory when Substance_classification_type= chemical, protein, polymer and nucleic acid.
Structural_represe
STR.1.CV The type of the structural representation shall be
CV
Y Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 43/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
ntation_type
described based on a controlled vocabulary. EXAMPLE: InChI, mol file
[Structural Representation Type]
Structural_representation
STR.2 The structural representation shall be provided. This shall contain only textual and not graphical information. When we enter more than one structural representation, the whole section is repeated (includes stereochemistry, optical activity etc) E.g. for an InChI code this field is populated with the InChI representation.
N/A Y Alphanumeric
4000
Structural_representation_attachment
STR.3 A copy of the structural representation shall be provided.
N .jpeg
Stereochemistry
STR.4.CV The stereochemistry of the substance shall be described based on a controlled vocabulary.
CV [Stereochemistry]
Y Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 44/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Optical_activity
STR.5.CV The optical activity shall be described based on a controlled vocabulary. EXAMPLE: (+), (-), (+/-)
CV [optical activity]
Y CV 250
Molecular_formula
STR.6 The molecular formula shall be provided. The molecular formula shall be specified with all the characters in capital letters.
N/A N Text 2000
Isotope (0..n)
STR.ISO The isotope section The isotope shall be described in this section, where applicable.
N
Nuclide_id
ISO.1 The identifier for each nuclide shall be provided based on a controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV.
CV [Substance Name]
N alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 45/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
Nuclide_name
ISO.2 The name for the nuclide shall be provided.
CV [Substance Name]
Y Text 4000
Substitution_type
ISO.3.CV The type of substitution shall be described using a controlled vocabulary. Substitution refers to the relationship between the nuclide and the rest of the substance EXAMPLE: specific; non-specific; unknown
CV [Substitution Type]
Y Text 250
Chemical (0..1)
SING.CHM The chemical substance section This section further defines the identifying characteristics of a chemical substance.
The section is mandatory if Substance_type_cv= Chemical
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 46/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Stoichiometric
CHM.1 The stoichiometric characteristics shall be specified based on a controlled vocabulary.
Yes/ No
Y Boolean
Comment
CHM.2 Any comment can be provided in this field, if necessary.
N/A N 4000
reference_source (1..n)
CHM.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary.
CV [Source
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 47/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: Regulatory submission
Class]
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
non_stoichiometric (1..1)
CHM.NS This section provides the non-stoichiometric characteristics of the chemical substance.
N
This section is mandatory when Stochiometric value= no
Number_of_moieties
NS.1 The number of moieties specified shall be provided. Non-stoichiometric chemical substances shall have at least two moieties.
N/A
Y Numeric
4 The numeric value shall be always ≥ 2 The value is automatically calculated.
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 48/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Each moiety shall be represented by a chemical structure.
Moiety (2..n)
NS.MOT The moiety section shall be provided. The moiety section serves for the description of both the moiety and the other fragment constituting the substance. EXAMPLE: Abacavir Sulphate Abacavir and sulfate shall be described separately based on this section characteristic.
Y The section is repeatable. The number of available section is = to the value given in Number_of_moieties.
Moiety_Role
MOT.1.CV The role of the moiety shall be described based on a controlled vocabulary. EXAMPLE: antigen, linker, conjugate
CV [Role]
Y text 250
Moiety_name
MOT.2 The name of the moiety shall be provided.
CV [Substance
Y Text 4000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 49/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
If the substance name is not present in the Controlled Vocabulary, the moiety name shall be described as a free text.
Name]
Moiety_id
MOT.3 The unique identifier assigned to the substance representing the moiety based on controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
CV [Substance Name]
N Alphanumeric
12
Amount_type
MOT.4.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
amount
MOT.AMT The amount section N
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 50/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
(0..1) Quantity
Operator AMT.1.CV CV
[Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_
AMT.7.CV The prefix of the lower limit unit of the substance shall be
CV
N alphanumer
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 51/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
denominator_unit_prefix
specified, where available.
[Unit Prefix] ic
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV
The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 52/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV
The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV
The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
Property (0..n)
NS.PROP The property section The characteristics of the property shall be described.
N
Property_type
PROP.1.CV The type of property shall be specified based on a controlled vocabulary. EXAMPLE: physical, chemical,
CV [Property Type]
Y Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 53/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
enzymatic, immunological
Property_name
PROP.2.CV The name of property shall be specified based on a Controlled Vocabulary.
CV [Parameter]
Y Text 250
Substance_id
PROP.3 The identifier of the substance related to a defining property shall be described where applicable and based on controlled vocabulary. EXAMPLE: solubility in Water, Water ID shall be specified NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
CV [Substance Name]
N Alphanumeric
12
Substance_name
PROP.4 The name of the substance related to a defining property
CV
N Text 4000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 54/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
shall be described where applicable. EXAMPLE: solubility in Water, Water shall be specified
[Substance Name]
Amount_type
PROP.5.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
Amount (1..1)
PROP.AMT The amount section Y
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numer
AMT.4.CV The prefix of the lower limit unit of the substance shall be
CV
N alphanumer
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 55/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
ator_unit_prefix
specified, where available.
[Unit Prefix] ic
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 56/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV
The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV
The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV
The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable.
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 57/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: Short, High (temperature)
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 58/485
4.3.2. SSI for Proteins
For substances that can be classified as proteins, the following data elements shall be specified:
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
substance
SUB
Language
SUB.LANG The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German
CV [Language]
Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology). For the purpose of describing “Language”, “T” shall be used. In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 59/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
language are to be considered synonyms.
Substance_id
COM.1 The substance identifier shall be described based on a controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
CV [Substance Name]
N Alphanumeric
12
Substance_Classification
COM.2.CV Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture
CV [Substance Class]
Y Text 250
substance_name (1..n)
COM.SNM The substance name section This section contains the set of elements for the description of
Y
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 60/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
the name of the substance. The latest version of the Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.
Substance_name
SNM.1 The name of the substance shall be specified.
Y Text 4000
Substance_name_type
SNM.2.CV The type of the name shall be specified based on a controlled vocabulary. EXAMPLE: Official name, Code
CV [Substance Name Type]
Y text 250
Language
SNM.3.CV The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German
CV [Language]
Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology).
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 61/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
For the purpose of describing “Language”, “T” shall be used. In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered synonyms.
official_name (0..n)
SNM.ON The official name section N If “Official Name” has been specified in “Substance_Name_Type” this section is mandatory. For any other name type, the section is present as not mandatory.
Official_name_type
ON.1.CV The type of the official name shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Official_name_status
ON.2.CV The status of the official name shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed
CV [Status]
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 62/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Official_name_status_change_date
ON.3 The change date of the status of the official name shall be specified in line with the ISO 8601 date format, which shall be only entered when name is changed. EXAMPLE: 2011-06-01
ISO 8601 date format
N alphanumeric
10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD
official_name_domain (1..n)
ON.DOM Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have at least one “Official Name Domain”.
Official_name_domain
DOM.1.CV The domain of the name shall be provided based on a controlled vocabulary. EXAMPLE: Human Pharmaceutical
CV [Domain]
Y Text 250
official_name_jurisdiction (1..n)
ON.JUR The jurisdiction of the official name section
Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 63/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
at least one “Official Name Jurisdiction”.
Official_name_jurisdiction
JUR.1.CV The jurisdiction of the official name shall be provided based on ISO 3166-1 alpha-2 codes with two exceptions: EL (not GR) is used to represent Greece, and UK (not GB) is used to represent the United Kingdom. For the European Union EU shall be used.
CV [Country Code]
Y Text 3
reference_source (1..n)
SNM.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Referenc RS.2.CV The type of the reference CV Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 64/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
e_source_type
source shall be specified based on a controlled vocabulary. EXAMPLE: INN
[Source]
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
substance_code
COM.SC The substance code section This section describes the specific code(s) within one or
N
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 65/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
(0..n) more available code system(s) that apply to a substance.
Code SC.1 The specific code (the value) with regard to a referenced code system shall be provided. NOTE: InChI is not considered a code and shall be specified within the structure description.
N/A Y alphanumeric
500
Code_system
SC.2.CV The code system shall be specified based on a controlled vocabulary.
CV [Code System]
Y
Text 250
Code_system_id
SC.3.CV The identifier for the code system shall be provided based on a controlled vocabulary.
CV [Code System]
N alphanumeric
12
Code_system_status
SC.4.CV The status of the code system shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed.
CV [Status]
Y text 250
Code_system_change_dat
SC.5 The change date of the code system shall be specified in line with the ISO 8601 date format,
ISO 8601 date format
N alphanumeric
10 This applies only when the code is changed, so it is not
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 66/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
e where applicable. EXAMPLE: 2011-06-01
applicable for initial submission. ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD
Comment
SC.6 Any comment can be provided in this field, if necessary.
N Text 4000
reference_source (1..n)
SC.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Referenc RS.2.CV The type of the reference CV Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 67/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
e_source_type
source shall be specified based on a controlled vocabulary. EXAMPLE: INN
[Source]
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
version (1..n)
COM.VER The version section This section shall provide information on the version of
Y Where no “Version Number” and “Effective Date” have been assigned by an authority
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 68/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
the substance. source, the version number shall be set as 0 with the date set as the date of initial submission of the substance.
Version_number
VER.1 The number of the version of the SSI shall be provided.
N/A Y numeric
4
Effective_date
VER.2 The date when the SSI was effective shall be provided in line with the ISO 8601 date format. This shall be defined when the SSI is generated or modified.
ISO 8601 date format
N alphanumeric
10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD
Change_made
VER.3 The description of the updates or changes of the SSI shall be specified. The field will be left empty when first insert of substance.
N/A
N text 4000
reference_information (1..1)
COM.RI The reference information section This section is used to provide details about:
Y
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 69/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
- substance classification - target - gene from which proteins are derived - substance relationship
Comment
RI.1 Any comment can be provided in this field, if necessary.
N Text 4000
substance_classification (1..n)
RI.SCLF The substance classification
Y One or more “Substance Classifications” shall be specified.
Domain SCLF.1.CV The domain of the substance classification shall be provided based on a controlled vocabulary. EXAMPLE: Human Pharmaceuticals
CV [Domain]
Y text 250
Substance_Classification
SCLF.2.CV Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture
CV [Substance Class]
Y Text 250 The information provided in this field shall be automatically populated based on the information provided in the Substance_Classification field (COM.2.CV).
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 70/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Substance_classification_type
SCLF.3.CV The type of the substance shall be provided based on a controlled vocabulary. NOTE: When Substance_Classification=mixture and the substances that are forming the mixture are of the same class, the class of those substances shall be specified in this field. EXAMPLE: two chemicals forming the mixture, specified_classification_type = chemical If the substances that are forming the mixture are of a different class, the value ‘mixture’ shall be specified in this field. EXAMPLE: One polymer combined in a protein, Specified_classification_type =mixture
CV [Substance Type] [Specified substance Type]
Y Text 250 When Substance_Classification= Single or mixture, the [Substance Type] CV applies. When Substance_Classification=Specified substance the [Specified Substance Type] CV applies.
Substance_classification_c
SCLF.4 The code of the classification type where applicable shall be specified based on a controlled
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 71/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
ode vocabulary.
subtype (1..n)
SCLF.ST The subtype section Y
Substance_class_subtype
ST.1.CV The sub-type of the classification shall be described based on a controlled vocabulary. EXAMPLE: Vaccine, Herbal, Multiple Substances
CV [Substance subtype]
Y Text 250
reference_source (1..n)
SCLF.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary.
CV [Source]
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 72/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: INN
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
substance_relationship (0..n)
RI.REL The substance relationship This section shall provide information related to relationship of a substance, where this is applicable.
N
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 73/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Relationship
REL.1.CV The relationship of a substance shall be defined based on a controlled vocabulary. NOTE: Target and gene elements are not to be specified in this section. EXAMPLE: transporter, metabolic enzyme
CV [relationship type]
Y Text 250
Interaction_type
REL.2.CV The type of interaction shall be specified based on a controlled vocabulary, where applicable. EXAMPLE: covalent
CV [Interaction Type]
N Text 250
Substance_id
REL.3 The substance identifier, for which the relationship is specified, shall be described. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique
CV [Substance Name]
N Alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 74/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
“Substance ID” e. g. for the initial submission of the substance this data element is not required.
Substance_name
REL.4 The substance name shall be specified.
CV [Substance Name]
Y text 4000 Mandatory when there is a “substance relationship”
Amount_type
REL.5.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
amount (0..1)
REL.AMT The amount section N
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 75/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Measure]
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 76/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
High_limit_numerator_unit_prefix
AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 77/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
reference_source (1..n)
REL.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source
RS.3.CV The class of the reference source shall be specified based
CV
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 78/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
_class on a controlled vocabulary. EXAMPLE: Regulatory submission
[Source Class]
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
gene (0..n)
RI.GN The gene section This section shall provide a description of the gene in relation to a substance, where applicable. The gene section refers only to gene that is the origin of the substance (protein).
N This section does not apply when Substance_classification_type is equal to chemical, Specified Substance Group 1, Specified Substance Group 2 and Specified substance group 3.
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 79/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Gene_sequence_origin
GN.1.CV The common name for the organism from which the final gene sequence originated shall be specified based on a controlled vocabulary. NOTE: it applies primarily to proteins.
CV [Organism Name]
N Text 4000
Gene_id GN.2 The identifier of the gene shall be provided based on a controlled vocabulary. E.g.: YP_299723.1
CV [Gene Name]
N alphanumeric
12
Gene_name
GN.3 The complete name given for a gene shall be provided based on a controlled vocabulary. E.g.: hIL-10 gene
CV [Gene Name]
Y Text 4000
reference_source (1..n)
GN.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 80/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference:
N/A N text 2500
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 81/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Encycl. 3: 429 (1792)
Gene_element (0..n)
RI.GE The gene element section N
Gene_element_type
GE.1.CV The type of the gene element shall be specified based on a controlled vocabulary. EXAMPLE: enhancer, promoter, silencer, terminator
CV [Gene Element Type]
Y Text 250
Gene_element_id
GE.2 The unique identifier for the gene element shall be specified based on a controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
CV [Substance Name]
N Alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 82/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Gene_element_name
GE.3 The specific gene element name shall be described based on a controlled vocabulary.
CV [Substance Name]
Y Text 4000
reference_source (1..n)
GE.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary.
CV [Source Class]
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 83/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: Regulatory submission
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
Target (0..n)
RI.TRG The target section This section shall provide information on the target substance. It refers for genes to the target of the protein expressed by that gene. For all the other substances type it refers to the substrate of the substance.
N This section does not apply when Substance_classification_type is equal to Specified Substance Group 1, Specified Substance Group 2 and Specified substance group 3.
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 84/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: enzyme, protein/channel, receptor
Target_gene_id
TRG.1 The identifier of the target gene shall be provided.
CV [Target Gene]
N
alphanumeric
12
Target_gene_name
TRG.2 The target gene name shall be specified based on a controlled vocabulary. EXAMPLE: single substance, an enzyme type
CV [Target Gene]
Y Text 4000
Interaction_type
TRG.3.CV The type of interaction shall be specified based on a controlled vocabulary. EXAMPLE: Inhibition
CV [Target interaction type]
Y text 250
Target_organism_type
TRG.4.CV The type of target organism shall be specified based on a controlled vocabulary. EXAMPLE: human, viral
CV [Organism type]
N Text 250
Target_type
TRG.5.CV The target type shall be specified based on a controlled vocabulary.
CV [Target type]
N Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 85/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: enzyme, receptor, membrane
reference_source (1..n)
TRG.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 86/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
Structure (0..n)
SING.STR The structure section The structure of the substance shall be described, where applicable
N The structure section is mandatory when Substance_classification_type= chemical, protein, polymer and nucleic acid.
Structural_representation_type
STR.1.CV The type of the structural representation shall be described based on a controlled vocabulary. EXAMPLE: InChI, mol file
CV [Structural Representation Type]
Y Text 250
Structural_representation
STR.2 The structural representation shall be provided. This shall contain only textual
N/A Y Alphanumeric
4000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 87/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
and not graphical information. When we enter more than one structural representation, the whole section is repeated (includes stereochemistry, optical activity etc) E.g. for an InChI code this field is populated with the InChI representation.
Structural_representation_attachment
STR.3 A copy of the structural representation shall be provided.
N .jpeg
Stereochemistry
STR.4.CV The stereochemistry of the substance shall be described based on a controlled vocabulary.
CV [Stereochemistry]
Y Text 250
Optical_activity
STR.5.CV The optical activity shall be described based on a controlled vocabulary. EXAMPLE: (+), (-), (+/-)
CV [optical activity]
Y CV 250
Molecula STR.6 The molecular formula shall be N/A N Text 2000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 88/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
r_formula
provided. The molecular formula shall be specified with all the characters in capital letters.
Isotope (0..n)
STR.ISO The isotope section The isotope shall be described in this section, where applicable.
N
Nuclide_id
ISO.1 The identifier for each nuclide shall be provided based on a controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
CV [Substance Name]
N alphanumeric
12
Nuclide_ ISO.2 The name for the nuclide shall CV Y Text 4000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 89/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
name be provided.
[Substance Name]
Substitution_type
ISO.3.CV The type of substitution shall be described using a controlled vocabulary. Substitution refers to the relationship between the nuclide and the rest of the substance EXAMPLE: specific; non-specific; unknown
CV [Substitution Type]
Y Text 250
Protein (0..1)
SING.PRO The protein section The identifying characteristics of the protein shall be specified in this section.
The section is mandatory if Substance_type_cv= Protein
Sequence_type
PRO.1.CV The type of the protein sequence shall be specified based on a controlled vocabulary. EXAMPLE: complete; Partial protein descriptive elements will only be used
CV [Sequence Type]
Y Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 90/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
when a complete or partial amino acid sequence is available or derivable from a nucleic acid sequence.
Number_of_subunits
PRO.2 The number of subunit constituting the protein shall be described. NOTE: If not specified in the reference source, the assumption is that there is 1 subunit.
N/A Y Numeric
4 The value is automatically calculated.
Disulfide_linkage
PRO.3 The position of the disulfide bonds in the protein shall be described. Each disulfidelinkage shall be specified followed by a comma and space (not-repeatable field). The position of the disulfide bonds in the protein shall be described in increasing order of subunit number and position within subunit followed by the abbreviation of the aminoacids involved.
N/A Y Alphanumeric
2500
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 91/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: - “Cys1_10-Cys2_16” refers to a disulfide linkage between the residue of cysteine in the position 10 and 16 respectively of the first and second subunit. If disulfide linkage are not present, the value N/A shall be specified.
Comment
PRO.4 Any comment can be provided in this field, if necessary.
N/A N Text 4000
protein_subunit (1..n)
PRO.PSU The protein subunit section This section refers to the description of each constituting the protein. The section is repeatable for each diverse subunit of the protein.
Y
Subunit PSU.1 The numeric value that relates back to the subunit shall be specified in order of decreasing length.
N/A Y Numeric
4
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 92/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Sequences of the same length will be ordered by molecular weight. Subunits that have identical sequences will be repeated and have sequential subscripts. EXAMPLE: 1,2,3,..
Sequence
PSU.2 Sequences shall be described using the standard single letter amino acid code. Transcribed proteins will always be described using the translated sequence.
N/A Y Text 4000
Length PSU.3 The number of amino acid residues linked through peptide bonds shall be specified.
N/A Y Alphanumeric
100
N_terminal_modification
PSU.4.CV The modification at the n-terminal of the protein shall be provided based on a controlled vocabulary.
CV [Modification]
Y Text 250
N_terminal_modification_id
PSU.5 The unique identifier assigned to the modification at the N-
CV [Modification]
N Alphanumeric
12 If N_terminal_modification value is not equal to unknown or not applicable, the
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 93/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
terminal of the protein based on a Controlled vocabulary.
N_terminal_modification_id field is mandatory.
C_terminal_modification
PSU.6.CV The modification at the c-terminal of the protein shall be provided based on a controlled vocabulary.
CV [Modification]
Y Text 250
C_terminal_modification_id
PSU.7 The unique identifier assigned to the modification at the C-terminal of the protein based on a Controlled vocabulary.
CV [Modification]
N Alphanumeric
12 If C_terminal_modification value is not equal to unknown or not applicable, the C_terminal_modification_id field is mandatory.
Glycosylation (0..n)
PRO.GLY The glycosilation section Details on the glycosilation shall be provided. The section is repeatable to allow the description of each glycosilation present in a protein.
N This section applies if the protein is glycosylated. The value of Glycosylation_type cannot be null. In case of no glycosilation the user must specify the value= Not applicable from the [Glycosylation Type] CV.
Glycosylation_type
GLY.1.CV The type of the glycosilation shall be specified based on a controlled vocabulary. EXAMPLE: human
CV [Glycosylation Type]
Y Text 250
N_glycos GLY.3 The site of n-glycosylation shall N/A N Alpha 4000 If Glycosylation_type = Not
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 94/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
ylation be described according to the protein sequence. The extent and type of the modification at a given site is not captured. The convention to be used is as follow: “3 Aminoacid code letter+subunit number”_”position of aminoacid” EXAMPLE: asparagine “Asn1_34”
numeric
applicable, this field is not applicable.
O_glycosylation
GLY.4 The site of the o-glycosylation shall be described. The convention to be used is as follow: “3 Aminoacid code letter+subunit number”_”position of aminoacid” EXAMPLE: serine “Ser2_34”
N/A N Alphanumeric
4000 If Glycosylation_type = Not applicable, this field is not applicable.
C_glycosylation
GLY.5 The site of the c-glycosylation shall be described.
N/A N Alphanumeric
4000 If Glycosylation_type = Not applicable, this field is not applicable.
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 95/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
The convention to be used is as follow: “3 Aminoacid code letter+subunit number”_”position of aminoacid” EXAMPLE: tryptophan “Trp2_45”
Modification (0..n)
PRO.MOD The modification section The modification details shall be specified.
N This section apply to: -Nucleic Acid -Protein -Polymer -Structurally Diverse Substances -Mixture This section shall be repeatable to describe each modification occurred on each residue modified.
Modification_type
MOD.1.CV The type of the modification shall be provided based on a controlled vocabulary. EXAMPLE: Structural
CV [Modification Type]
Y Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 96/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Residue_modified
MOD.2.CV The name of the residue modified shall be described based on controlled vocabulary. NOTE: For virus or bacteria the value residue modified is = not applicable;
CV [Nucleotide Bases] OR [Aminoacid] OR [Substance Name]
Y Text 4000 If Substance_classification_type= protein, the CV [Amino acid] applies; If Substance_classification_type= nucleic acid, the CV [Nucleotide Bases] applies; If Substance_classification_type= polymer, the CV [Substance Name] applies. If Substance_classification_type= Structurally Diverse Substance or Mixture, the value residue modified is= not applicable
Residue_site
MOD.3 The position of specific residue undergone to modifications shall be described. Each residue shall be specified followed by a comma and space.
N Text 2000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 97/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
For protein and nucleic acid, the number of the subunit followed by the number of the residue modified shall be specified. The underscore “_” shall be used as separator. EXAMPLE: 1_10 refers to the 10th residue on the 1st subunit Or A1_10
physical_modification (0..n)
MOD.PM The physical modification section
N This section shall only apply if Modification_type= Physical
Role PM.1.CV The role of the physical modification shall be provided based on a controlled vocabulary. EXAMPLE: inactivation, activation
CV [Modification]
Y Text 250
Number_of_para
PM.2 The number of parameter that is going to be described as
No N Numeric
4 The value is automatically calculated.
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 98/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
meters result of the modification shall be provided.
Parameter (0..n)
PM.PARA The parameter section N The repeatability of this section is strictly related to the Value of the “Number_of_ Parameter” field. The section shall be repeated as many time as specified in the ‘number_of_parameters’ field.
Parameter
PARA.1.CV The parameter shall be described based on controlled vocabulary. EXAMPLE: time, temperature, pressure
CV [Parameter]
Y Text 250
Amount_type
PARA.2.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
amount (0..1)
PARA.AMT The amount section N
Quantity Operator
AMT.1.CV CV [Quantity
N text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 99/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Operator]
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_lim AMT.8 The higher limit value of the N Nume 10
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 100/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
it_numerator_value
substance shall be specified, where available.
ric
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV
The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 101/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Prefix AMT.15.CV
The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV
The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
structural_modification (0..n)
MOD.SM The structural modification section
N This section shall apply if Modification_type= Structural This section is repeatable.
Structural_modification_type
SM.1.CV The type of the structural modification shall be described based on a controlled vocabulary
CV [Modification]
Y Text 250
Moiety (0..n)
SM.MOT The moiety section This section describes the
N
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 102/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
moiety affected by the modification where applicable.
Moiety_Role
MOT.1.CV The role of the moiety shall be described based on a controlled vocabulary. EXAMPLE: antigen, linker, conjugate
CV [Role]
Y text 250
Moiety_name
MOT.2 The name of the moiety shall be provided. If the substance name is not present in the Controlled Vocabulary, the moiety name shall be described as a free text.
CV [Substance Name]
Y Text 4000
Moiety_id
MOT.3 The unique identifier assigned to the substance representing the moiety based on controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV.
CV [Substance Name]
N Alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 103/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
Amount_type
MOT.4.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
amount (0..1)
MOT.AMT The amount section N
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numer
AMT.4.CV The prefix of the lower limit unit of the substance shall be
CV
N alphanumer
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 104/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
ator_unit_prefix
specified, where available.
[Unit Prefix] ic
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 105/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV
The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV
The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV
The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable.
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 106/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: Short, High (temperature)
molecular_fragment (0..n)
SM.MFRAG The molecular fragment section. This section describes the molecular fragment affected by the modification where applicable.
N
Role MFRAG.1.CV
The role of the molecular fragment shall be described based on a controlled vocabulary.
CV [Role]
Y Text 250
Molecular_fragment_id
MFRAG.2 The unique identifier for molecular fragment shall be provided.
CV [Substance Name]
N Alphanumeric
12
Molecular_fragment_name
MFRAG.3 The name for molecular fragment shall be specified.
CV [Substance Name]
Y Text 4000
Amount_type
MFRAG.4.CV
The type of the amount of the substance shall be specified
CV
N Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 107/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
using a controlled vocabulary.
[Amount Type]
amount (0..1)
MFRAG.AMT
The amount section N
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denomin
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 108/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
ator _unit
Measure]
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV
The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 109/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
High_limit_ denominator_unit_prefix
AMT.13.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV
The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV
The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
agent_modification (0..n)
MOD.AM The modification agent section. This section described the agent that caused the modification.
N
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 110/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Agent_modification_type
AM.1.CV The type of the agent used for the modification shall be specified based on a controlled vocabulary. EXAMPLE: chemical, enzymatic
CV [Agent Modification Type]
Y text 250
Role AM.2.CV The role of the modification agent shall be specified based on a controlled vocabulary.
CV [Modification]
Y Text 250
Modification_agent
AM.3 The name of modifying agent shall be specified based on a controlled vocabulary.
CV [Substance Name]
Y Text 4000
Modification_agent_id
AM.4 The unique identifier of modifying agent shall be provided. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the
CV [Substance Name]
N Alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 111/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
initial submission of the substance this data element is not required.
Modification_process
AM.5.CV The modification process shall be specified based on a controlled vocabulary. EXAMPLE: UV irradiation
CV [Modification Process]
N Text
250
Amount_type
AM.6.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
amount (0..1)
AM.AMT The amount section N
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 112/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_lim AMT.10.C The prefix of the higher limit CV N alpha 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 113/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
it_numerator_unit_prefix
V unit of the substance shall be specified, where available.
[Unit Prefix]
numeric
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV
The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV
The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV
The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 114/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
molecular_weight (0..n)
PRO.MWT The molecular weight section N The section is mandatory if Substance_classification_type= protein, polymer or nucleic acid
Molecular_weight_method
MWT.1.CV The method used to measure the molecular weight shall be specified based on a controlled vocabulary. EXAMPLE: sds_page
CV [Method of Measure]
Y text 250
Molecular_weight_type
MWT.2.CV The type of the molecular weight shall be specified based on a controlled vocabulary.
CV [Molecular Weight Type]
Y Text 250
Amount_type
MWT.3.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
Amount
MW.AMT The amount section Y
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 115/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
(1..1) Quantity
Operator AMT.1.CV CV
[Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_
AMT.7.CV The prefix of the lower limit unit of the substance shall be
CV
N alphanumer
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 116/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
denominator_unit_prefix
specified, where available.
[Unit Prefix] ic
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV
The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 117/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV
The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV
The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
Property (0..n)
PRO.PROP The property section The characteristics of the property shall be described.
N
Property_type
PROP.1.CV
The type of property shall be specified based on a controlled vocabulary. EXAMPLE: physical, chemical,
CV [Property Type]
Y Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 118/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
enzymatic, immunological
Property_name
PROP.2.CV
The name of property shall be specified based on a Controlled Vocabulary.
CV [Parameter]
Y Text 250
Substance_id
PROP.3 The identifier of the substance related to a defining property shall be described where applicable and based on controlled vocabulary. EXAMPLE: solubility in Water, Water ID shall be specified NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
CV [Substance Name]
N Alphanumeric
12
Substance_name
PROP.4 The name of the substance related to a defining property
CV
N Text 4000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 119/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
shall be described where applicable. EXAMPLE: solubility in Water, Water shall be specified
[Substance Name]
Amount_type
PROP.5.CV
The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
amount (1..1)
PROP.AMT The amount section Y
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerator_unit
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 120/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
_prefix
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limi AMT.11 The higher limit value of the N Nume 10
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 121/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
t_denominator_value
substance shall be specified, where available.
ric
High_limit_ denominator _unit
AMT.12.CV
The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV
The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV
The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable.
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 122/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: Short, High (temperature)
reference_source (1..n)
PRO.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 123/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
4.3.3. SSI for nucleic acids
For substances, which can be classified as nucleic acid the SSI the following data elements shall be specified:
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 124/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
substance
SUB
Language
SUB.LANG The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German
CV [Language]
Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology). For the purpose of describing “Language”, “T” shall be used. In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered synonyms.
Substance_id
COM.1 The substance identifier shall be described based on a controlled vocabulary.
CV [Substance Name]
N Alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 125/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
Substance_Classification
COM.2.CV Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture
CV [Substance Class]
Y Text 250
substance_name (1..n)
COM.SNM The substance name section This section contains the set of elements for the description of the name of the substance. The latest version of the Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.
Y
Substance_name
SNM.1 The name of the substance shall be specified.
Y Text 4000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 126/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
Substance_name_type
SNM.2.CV The type of the name shall be specified based on a controlled vocabulary. EXAMPLE: Official name, Code
CV [Substance Name Type]
Y text 250
Language SNM.3.CV The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German
CV [Language]
Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology). For the purpose of describing “Language”, “T” shall be used. In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered synonyms.
official_name (0..n)
SNM.ON The official name section N If “Official Name” has been specified in “Substance_Name_Type” this section is mandatory.
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 127/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
For any other name type, the section is present as not mandatory.
Official_name_type
ON.1.CV The type of the official name shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Official_name_status
ON.2.CV The status of the code system shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed.
CV [Status]
Y text 250
Official_name_status_change_date
ON.3 The change date of the status of the official name shall be specified in line with the ISO 8601 date format, which shall be only entered when name is changed. EXAMPLE: 2011-06-01
ISO 8601 date format
N alphanumeric
10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD
official_name_domain (1..n)
ON.DOM Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 128/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
at least one “Official Name Domain”.
Official_name_domain
DOM.1.CV The domain of the name shall be provided based on a controlled vocabulary. EXAMPLE: Human Pharmaceutical
CV [Domain]
Y Text 250
official_name_jurisdiction (1..n)
ON.JUR The jurisdiction of the official name section
Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have at least one “Official Name Jurisdiction”.
Official_name_jurisdiction
JUR.1.CV The jurisdiction of the official name shall be provided based on ISO 3166-1 alpha-2 codes with two exceptions: EL (not GR) is used to represent Greece, and UK (not GB) is used to represent the United Kingdom. For the European Union EU shall be used.
CV [Country Code]
Y Text 3
reference_source
SNM.RS The reference source section This section describes the
Y
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 129/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
(1..n)
reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described.
N/A N text 2500
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 130/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
substance_code (0..n)
COM.SC The substance code section This section describes the specific code(s) within one or more available code system(s) that apply to a substance.
N
Code SC.1 The specific code (the value) with regard to a referenced code system shall be provided. NOTE: InChI is not considered a code and shall be specified within the structure description.
N/A Y alphanumeric
500
Code_system
SC.2.CV The code system shall be specified based on a controlled vocabulary.
CV [Code System]
Y
Text 250
Code_system_id
SC.3.CV The identifier for the code system shall be provided based on a controlled vocabulary.
CV [Code System]
N alphanumeric
12
Code_system_stat
SC.4.CV The status of the code system shall be specified based on a
CV
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 131/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
us controlled vocabulary. EXAMPLE: current, proposed.
[Status]
Code_system_change_date
SC.5 The change date of the code system shall be specified in line with the ISO 8601 date format, where applicable. EXAMPLE: 2011-06-01
ISO 8601 date format
N alphanumeric
10 This applies only when the code is changed, so it is not applicable for initial submission. ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD
Comment SC.6 Any comment can be provided in this field, if necessary.
N Text 4000
reference_source (1..n)
SC.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is
Yes /No
Y Boolean
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 132/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
public or not. Yes or No values apply.
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
version
COM.VER The version section
Y Where no “Version Number”
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 133/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
(1..n) This section shall provide information on the version of the substance.
and “Effective Date” have been assigned by an authority source, the version number shall be set as 0 with the date set as the date of initial submission of the substance.
Version_number
VER.1 The number of the version of the SSI shall be provided.
N/A Y numeric
4
Effective_date
VER.2 The date when the SSI was effective shall be provided in line with the ISO 8601 date format. This shall be defined when the SSI is generated or modified.
ISO 8601 date format
N alphanumeric
10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD
Change_made
VER.3 The description of the updates or changes of the SSI shall be specified. The field will be left empty when first insert of substance.
N/A
N text 4000
reference_information (1..1)
COM.RI The reference information section This section is used to provide details about: - substance classification
Y
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 134/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
- target - gene from which proteins are derived - substance relationship
Comment RI.1 Any comment can be provided in this field, if necessary.
N Text 4000
substance_classification (1..n)
RI.SCLF The substance classification
Y One or more “Substance Classifications” shall be specified.
Domain SCLF.1.CV The domain of the substance classification shall be provided based on a controlled vocabulary. EXAMPLE: Human Pharmaceuticals
CV [Domain]
Y text 250
Substance_Classification
SCLF.2.CV Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture
CV [Substance Class]
Y Text 250 The information provided in this field shall be automatically populated based on the information provided in the Substance_Classification field (COM.2.CV).
Substance_classification_ty
SCLF.3.CV The type of the substance shall be provided based on a controlled vocabulary.
CV [Substance Type]
Y Text 250 When Substance_Classification= Single or mixture, the
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 135/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
pe NOTE: When Substance_Classification=mixture and the substances that are forming the mixture are of the same class, the class of those substances shall be specified in this field. EXAMPLE: two chemicals forming the mixture, specified_classification_type = chemical If the substances that are forming the mixture are of a different class, the value ‘mixture’ shall be specified in this field. EXAMPLE: One polymer combined in a protein, Specified_classification_type =mixture
[Specified substance Type]
[Substance Type] CV applies. When Substance_Classification=Specified substance the [Specified Substance Type] CV applies.
Substance_classification_code
SCLF.4 The code of the classification type where applicable shall be specified based on a controlled vocabulary.
N alphanumeric
250
subtype (1..n)
SCLF.ST The subtype section Y
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 136/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
Substance_class_subtype
ST.1.CV The sub-type of the classification shall be described based on a controlled vocabulary. EXAMPLE: Vaccine, Herbal, Multiple Substances
CV [Substance subtype]
Y Text 250
reference_source (1..n)
SCLF.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 137/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
substance_relationship (0..n)
RI.REL The substance relationship This section shall provide information related to relationship of a substance, where this is applicable.
N
Relationship
REL.1.CV The relationship of a substance shall be defined based on a controlled vocabulary. NOTE: Target and gene elements are not to be specified in this section. EXAMPLE: transporter, metabolic enzyme
CV [relationship type]
Y Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 138/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
Interaction_type
REL.2.CV The type of interaction shall be specified based on a controlled vocabulary, where applicable. EXAMPLE: covalent
CV [Interaction Type]
N Text 250
Substance_id
REL.3 The substance identifier, for which the relationship is specified, shall be described. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
CV [Substance Name]
N Alphanumeric
12
Substance_name
REL.4 The substance name shall be specified.
CV [Substance Name]
Y text 4000 Mandatory when there is a “substance relationship”
Amount_type
REL.5.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 139/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
amount (0..1)
REL.AMT The amount section N
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_
AMT.7.CV The prefix of the lower limit unit of the substance shall be
CV
N alphanume
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 140/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
denominator_unit_prefix
specified, where available.
[Unit Prefix] ric
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV
The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 141/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
Prefix AMT.15.CV
The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV
The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
reference_source (1..n)
REL.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary.
CV [Source]
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 142/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
EXAMPLE: INN
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
gene (0..n)
RI.GN The gene section This section shall provide a description of the gene in relation to a substance, where applicable. The gene section refers only to gene that is the origin of the
N This section does not apply when Substance_classification_type is equal to chemical, Specified Substance Group 1, Specified Substance Group 2 and Specified substance group 3.
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 143/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
substance (protein).
Gene_sequence_origin
GN.1.CV The common name for the organism from which the final gene sequence originated shall be specified based on a controlled vocabulary. NOTE: it applies primarily to proteins.
CV [Organism Name]
N Text 4000
Gene_id GN.2 The identifier of the gene shall be provided based on a controlled vocabulary. E.g.: YP_299723.1
CV [Gene Name]
N alphanumeric
12
Gene_name
GN.3 The complete name given for a gene shall be provided based on a controlled vocabulary. E.g.: hIL-10 gene
CV [Gene Name]
Y Text 4000
reference_source (1..n)
GN.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 144/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 145/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
Gene_element (0..n)
RI.GE The gene element section N
Gene_element_type
GE.1.CV The type of the gene element shall be specified based on a controlled vocabulary. EXAMPLE: enhancer, promoter, silencer, terminator
CV [Gene Element Type]
Y Text 250
Gene_element_id
GE.2 The unique identifier for the gene element shall be specified based on a controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
CV [Substance Name]
N Alphanumeric
12
Gene_element_name
GE.3 The specific gene element name shall be described based on a controlled vocabulary.
CV [Substance Name]
Y Text 4000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 146/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
reference_source (1..n)
GE.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 147/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
Target (0..n)
RI.TRG The target section This section shall provide information on the target substance. It refers for genes to the target of the protein expressed by that gene. For all the other substances type it refers to the substrate of the substance. EXAMPLE: enzyme, protein/channel, receptor
N This section does not apply when Substance_classification_type is equal to Specified Substance Group 1, Specified Substance Group 2 and Specified substance group 3.
Target_gene_id
TRG.1 The identifier of the target gene shall be provided.
CV [Target Gene]
N alphanumeric
12
Target_gene_nam
TRG.2 The target gene name shall be specified based on a controlled
CV
Y Text 4000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 148/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
e vocabulary. EXAMPLE: single substance, an enzyme type
[Target Gene]
Interaction_type
TRG.3.CV The type of interaction shall be specified based on a controlled vocabulary. EXAMPLE: Inhibition
CV [Target interaction type]
Y text 250
Target_organism_type
TRG.4.CV The type of target organism shall be specified based on a controlled vocabulary. EXAMPLE: human, viral
CV [Organism type]
N Text 250
Target_type
TRG.5.CV The target type shall be specified based on a controlled vocabulary. EXAMPLE: enzyme, receptor, membrane
CV [Target type]
N Text 250
reference_source (1..n)
TRG.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is
Yes /No
Y Boolean
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 149/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
public or not. Yes or No values apply.
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
Structure
SING.STR The structure section
N The structure section is mandatory when
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 150/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
(0..n) The structure of the substance shall be described, where applicable
Substance_classification_type= chemical, protein, polymer and nucleic acid.
Structural_representation_type
STR.1.CV The type of the structural representation shall be described based on a controlled vocabulary. EXAMPLE: InChI , mol file
CV [Structural Representation Type]
Y Text 250
Structural_representation
STR.2 The structural representation shall be provided. This shall contain only textual and not graphical information. When we enter more than one structural representation, the whole section is repeated (includes stereochemistry, optical activity etc) E.g. for an InChI code this field is populated with the InChI representation.
N/A Y Alphanumeric
4000
Structural_representation_attachment
STR.3 A copy of the structural representation shall be provided.
N .jpeg
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 151/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
Stereochemistry
STR.4.CV The stereochemistry of the substance shall be described based on a controlled vocabulary.
CV [Stereochemistry]
Y Text 250
Optical_activity
STR.5.CV The optical activity shall be described based on a controlled vocabulary. EXAMPLE: (+), (-), (+/-)
CV [optical activity]
Y CV 250
Molecular_formula
STR.6 The molecular formula shall be provided. The molecular formula shall be specified with all the characters in capital letters.
N/A N Text 2000
Isotope (0..n)
STR.ISO The isotope section The isotope shall be described in this section, where applicable.
N
Nuclide_id
ISO.1 The identifier for each nuclide shall be provided based on a controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the
CV [Substance Name]
N alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 152/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
Nuclide_name
ISO.2 The name for the nuclide shall be provided.
CV [Substance Name]
Y Text 4000
Substitution_type
ISO.3.CV The type of substitution shall be described using a controlled vocabulary. Substitution refers to the relationship between the nuclide and the rest of the substance EXAMPLE: specific; non-specific; unknown
CV [Substitution Type]
Y Text 250
nucleic_acid (0..1)
SING.NA This section provides a description of the identifying characteristics of a nucleic acid.
The section is mandatory if Substance_type_cv= Nucleic Acid
Sequence_type
NA.1.CV The type of the sequence shall be specified based on a controlled vocabulary.
CV [Sequence Type]
Y Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 153/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
NOTE: complete, partial protein descriptive elements will only be used when a complete or partial amino acid sequence is available or derivable from a nucleic acid sequence.
Number_of_subunits
NA.2 The number of linear sequences of nucleotides linked through phosphodiesteric bonds shall be described. NOTE: If not specified in the reference source, the assumption is that there is 1 subunit.
N/A Y Numeric
4 The value is automatically calculated.
Area_of_hybridisation
NA.3.CV The area of hydbridization shall be described if applicable. The number associated with the subunit followed by the number associated to the residue shall be specified in increasing order. The underscore “_” shall be used as separator as follow: “Subunit_number Residue”. EXAMPLE: 1_10 refers to the 10th residue on the 1st subunit
N/A N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 154/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
Or A1_10, A1_11 Each residue shall be specified followed by a comma and space.
Comment NA.4 Any comment can be provided in this field, if necessary.
N Text 4000
nucleic_acid_subunit (1..n)
NA.NASU The nucleic acid subunit This section describes the nucleic acid subunits.
Y This section is repeatable for each subunit.
Subunit NASU.1 The numeric value that relates back to subunit shall be specified in order of decreasing length. Sequences of the same length will be ordered by molecular weight. Subunits that have identical sequences will be repeated and have sequential subscripts. EXAMPLE: 1,2,3,..
N/A Y Numeric
4
Sequence NASU.2 The nucleotide sequence shall be specified.
N/A Y Alphanumeric
4000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 155/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
Length NASU.3 The number of nucleotide residues linked through phosphate esters shall be specified.
N/A N Alphanumeric
100
Five_prime
NASU.4.CV
The nucleotide present at the 5’ terminal shall be specified based on a controlled vocabulary. NOTE: If not specified in the available reference source this value shall be derived from the nucleic acid sequence.
CV: [Nucleotide Bases]
Y Text 250
Three_prime
NASU.5.CV
The nucleotide present at the 3’ terminal shall be specified based on a controlled vocabulary. NOTE: If not specified in the available reference source this value shall be derived from the nucleic acid sequence.
CV [Nucleotide Bases]
Y Text 250
Modification (0..n)
NA.MOD The modification section The modification details shall be specified.
N This section apply to: -Nucleic Acid -Protein -Polymer -Structurally Diverse Substances -Mixture
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 156/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
This section shall be repeatable to describe each modification occurred on each residue modified.
Modification_type
MOD.1.CV The type of the modification shall be provided based on a controlled vocabulary. EXAMPLE: Structural
CV [Modification Type]
Y Text 250
Residue_modified
MOD.2.CV The name of the residue modified shall be described based on controlled vocabulary. NOTE: For virus or bacteria the value residue modified is = not applicable;
CV [Nucleotide Bases] OR [Aminoacid] OR [Substance Name]
Y Text 4000 If Substance_classification_type= protein, the CV [Amino acid] applies; If Substance_classification_type= nucleic acid, the CV [Nucleotide Bases] applies; If Substance_classification_type= polymer, the CV [Substance Name] applies. If Substance_classification_type= Structurally Diverse Substance or Mixture, the value residue
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 157/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
modified is= not applicable
Residue_site
MOD.3 The position of specific residue undergone to modifications shall be described. Each residue shall be specified followed by a comma and space. For protein and nucleic acid, the number of the subunit followed by the number of the residue modified shall be specified. The underscore “_” shall be used as separator. EXAMPLE: 1_10 refers to the 10th residue on the 1st subunit Or A1_10
N Text 2000
physical_modification (0..n)
MOD.PM The physical modification section N This section shall only apply if Modification_type= Physical
Role PM.1.CV The role of the physical modification shall be provided based on a controlled
CV [Modification]
Y Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 158/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
vocabulary. EXAMPLE: inactivation, activation
Number_of_parameters
PM.2 The number of parameter that is going to be described as result of the modification shall be provided.
No N Numeric
4 The value is automatically calculated.
Parameter (0..n)
PM.PARA The parameter section N The repeatability of this section is strictly related to the Value of the “Number_of_ Parameter” field. The section shall be repeated as many time as specified in the ‘number_of_parameters’ field.
Parameter
PARA.1.CV
The parameter shall be described based on controlled vocabulary. EXAMPLE: time, temperature, pressure
CV [Parameter]
Y Text 250
Amount_type
PARA.2.CV
The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
amount
PARA.AMT The amount section N
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 159/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
(0..1) Quantity
Operator AMT.1.CV CV
[Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limi AMT.8 The higher limit value of the N Nume 10
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 160/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
t_numerator_value
substance shall be specified, where available.
ric
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV
The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV
The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 161/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
Unit AMT.16.CV
The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
structural_modification (0..n)
MOD.SM The structural modification section
N This section shall apply if Modification_type= Structural This section is repeatable.
Structural_modification_type
SM.1.CV The type of the structural modification shall be described based on a controlled vocabulary
CV [Modification]
Y Text 250
Moiety (0..n)
SM.MOT The moiety section This section describes the moiety affected by the modification where applicable.
N
Moiety_Role
MOT.1.CV The role of the moiety shall be described based on a controlled vocabulary. EXAMPLE: antigen, linker,
CV [Role]
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 162/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
conjugate
Moiety_name
MOT.2 The name of the moiety shall be provided. If the substance name is not present in the Controlled Vocabulary, the moiety name shall be described as a free text.
CV [Substance Name]
Y Text 4000
Moiety_id MOT.3 The unique identifier assigned to the substance representing the moiety based on controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
CV [Substance Name]
N Alphanumeric
12
Amount_type
MOT.4.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 163/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
amount (0..1)
MOT.AMT The amount section N
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_ denominator_unit_
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 164/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
prefix
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV
The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV
The prefix of the average unit of the substance shall be specified,
CV
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 165/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
where available.
[Unit Prefix]
Unit AMT.16.CV
The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
molecular_fragment (0..n)
SM.MFRAG
The molecular fragment section. This section describes the molecular fragment affected by the modification where applicable.
N
Role MFRAG.1.CV
The role of the molecular fragment shall be described based on a controlled vocabulary.
CV [Role]
Y Text 250
Molecular_fragment_id
MFRAG.2 The unique identifier for molecular fragment shall be provided. NOTE: If a unique “Substance ID”
CV [Substance Name]
N Alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 166/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
(EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
Molecular_fragment_name
MFRAG.3 The name for molecular fragment shall be specified.
CV [Substance Name]
Y Text 4000
Amount_type
MFRAG.4.CV
The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
amount (0..1)
MFRAG.AMT
The amount section N
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 167/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_
AMT.10.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 168/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
prefix
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV
The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV
The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV
The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 169/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
agent_modification (0..n)
MOD.AM The modification agent section. This section described the agent that caused the modification.
N
Agent_modification_type
AM.1.CV The type of the agent used for the modification shall be specified based on a controlled vocabulary. EXAMPLE: chemical, enzymatic
CV [Agent Modification Type]
Y text 250
Role AM.2.CV The role of the modification agent shall be specified based on a controlled vocabulary.
CV [Modification]
Y Text 250
Modification_agent
AM.3 The name of modifying agent shall be specified based on a controlled vocabulary.
CV [Substance Name]
Y Text 4000
Modification_agent_id
AM.4 The unique identifier of modifying agent shall be provided. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the
CV [Substance Name]
N Alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 170/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
Modification_process
AM.5.CV The modification process shall be specified based on a controlled vocabulary. EXAMPLE: UV irradiation
CV [Modification Process]
N Text
250
Amount_type
AM.6.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
amount (0..1)
AM.AMT The amount section N
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerat
AMT.3.CV The lower limit unit of the substance shall be specified,
CV
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 171/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
or_unit where available.
[Unit of Measure]
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limi AMT.11 The higher limit value of the N Numer 10
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 172/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
t_denominator_value
substance shall be specified, where available.
ic
High_limit_ denominator _unit
AMT.12.CV
The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV
The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV
The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
Property NA.PROP The property section N
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 173/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
(0..n)
The characteristics of the property shall be described.
Property_type
PROP.1.CV
The type of property shall be specified based on a controlled vocabulary. EXAMPLE: physical, chemical, enzymatic, immunological
CV [Property Type]
Y Text 250
Property_name
PROP.2.CV
The name of property shall be specified based on a Controlled Vocabulary.
CV [Parameter]
Y Text 250
Substance_id
PROP.3 The identifier of the substance related to a defining property shall be described where applicable and based on controlled vocabulary. EXAMPLE: solubility in Water, Water ID shall be specified NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
CV [Substance Name]
N Alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 174/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
Substance_name
PROP.4 The name of the substance related to a defining property shall be described where applicable. EXAMPLE: solubility in Water, Water shall be specified
CV [Substance Name]
N Text 4000
Amount_type
PROP.5.CV
The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
Amount (1..1)
PROP.AMT The amount section Y
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 175/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_
AMT.12.CV
The higher limit unit of the substance shall be specified, where available.
CV
N alphanum
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 176/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
denominator _unit
[Unit of Measure]
eric
High_limit_ denominator_unit_prefix
AMT.13.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV
The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV
The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
molecular_weight (0..n)
NA.MWT The molecular weight section N The section is mandatory if Substance_classification_type= protein, polymer or nucleic acid
Molecular_weight_method
MWT.1.CV The method used to measure the molecular weight shall be specified based on a controlled vocabulary.
CV [Method of
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 177/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
EXAMPLE: sds_page
Measure]
Molecular_weight_type
MWT.2.CV The type of the molecular weight shall be specified based on a controlled vocabulary.
CV [Molecular Weight Type]
Y Text 250
Amount_type
MWT.3.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
Amount (1..1)
MWT.AMT The amount section Y
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerat
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where
CV
N alphanum
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 178/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
or_unit_prefix
available.
[Unit Prefix] eric
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 179/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
High_limit_ denominator _unit
AMT.12.CV
The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV
The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV
The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
reference_source (1..n)
NA.RS The reference source section This section describes the reference source information.
Y
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 180/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
For each “Substance Name” a “Reference Source” shall be specified.
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 181/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference Mandatory
Type Field Length
Business Rules
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 182/485
4.3.4. SSI for Polymers
For substances that can be classified as polymers, the following data elements shall be specified:
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
substance SUB
Language
SUB.LANG The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German
CV [Language]
Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology). For the purpose of describing “Language”, “T” shall be used. In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered synonyms.
Substance_id
COM.1 The substance identifier shall be described based on a controlled vocabulary. NOTE:
CV [Substance Name]
N Alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 183/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
Substance_Classification
COM.2.CV Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture
CV [Substance Class]
Y Text 250
substance_name (1..n)
COM.SNM The substance name section This section contains the set of elements for the description of the name of the substance. The latest version of the Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.
Y
Substance_name
SNM.1 The name of the substance shall be specified.
Y Text 4000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 184/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Substance_name_type
SNM.2.CV The type of the name shall be specified based on a controlled vocabulary. EXAMPLE: Official name, Code
CV [Substance Name Type]
Y text 250
Language
SNM.3.CV The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German
CV [Language]
Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology). For the purpose of describing “Language”, “T” shall be used. In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered synonyms.
official_name
SNM.ON The official name section N If “Official Name” has been specified in “Substance_Name_Type” this
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 185/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
(0..n) section is mandatory. For any other name type, the section is present as not mandatory.
Official_name_type
ON.1.CV The type of the official name shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Official_name_status
ON.2.CV The status of the code system shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed.
CV [Status]
Y text 250
Official_name_status_change_date
ON.3 The change date of the status of the official name shall be specified in line with the ISO 8601 date format, which shall be only entered when name is changed. EXAMPLE: 2011-06-01
ISO 8601 date format
N alphanumeric
10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD
official_name_domain (1..n)
ON.DOM Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 186/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
at least one “Official Name Domain”.
Official_name_domain
DOM.1.CV The domain of the name shall be provided based on a controlled vocabulary. EXAMPLE: Human Pharmaceutical
CV [Domain]
Y Text 250
official_name_jurisdiction (1..n)
ON.JUR The jurisdiction of the official name section
Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have at least one “Official Name Jurisdiction”.
Official_name_jurisdiction
JUR.1.CV The jurisdiction of the official name shall be provided based on ISO 3166-1 alpha-2 codes with two exceptions: EL (not GR) is used to represent Greece, and UK (not GB) is used to represent the United Kingdom. For the European Union EU shall be used.
CV [Country Code]
Y Text 3
reference_source (1..n)
SNM.RS The reference source section This section describes the reference source information.
Y
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 187/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
For each “Substance Name” a “Reference Source” shall be specified.
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference:
N/A N text 2500
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 188/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Encycl. 3: 429 (1792)
substance_code (0..n)
COM.SC The substance code section This section describes the specific code(s) within one or more available code system(s) that apply to a substance.
N
Code SC.1 The specific code (the value) with regard to a referenced code system shall be provided. NOTE: InChI is not considered a code and shall be specified within the structure description.
N/A Y alphanumeric
500
Code_system
SC.2.CV The code system shall be specified based on a controlled vocabulary.
CV [Code System]
Y
Text 250
Code_system_id
SC.3.CV The identifier for the code system shall be provided based on a controlled vocabulary.
CV [Code System]
N alphanumeric
12
Code_system_status
SC.4.CV The status of the code system shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed.
CV [Status]
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 189/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Code_system_change_date
SC.5 The change date of the code system shall be specified in line with the ISO 8601 date format, where applicable. EXAMPLE: 2011-06-01
ISO 8601 date format
N alphanumeric
10 This applies only when the code is changed, so it is not applicable for initial submission. ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD
Comment
SC.6 Any comment can be provided in this field, if necessary.
N Text 4000
reference_source (1..n)
SC.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 190/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
version (1..n)
COM.VER The version section This section shall provide information on the version of the substance.
Y Where no “Version Number” and “Effective Date” have been assigned by an authority source, the version number
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 191/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
shall be set as 0 with the date set as the date of initial submission of the substance.
Version_number
VER.1 The number of the version of the SSI shall be provided.
N/A Y numeric
4
Effective_date
VER.2 The date when the SSI was effective shall be provided in line with the ISO 8601 date format. This shall be defined when the SSI is generated or modified.
ISO 8601 date format
N alphanumeric
10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD
Change_made
VER.3 The description of the updates or changes of the SSI shall be specified. The field will be left empty when first insert of substance.
N/A
N text 4000
reference_information (1..1)
COM.RI The reference information section This section is used to provide details about: - substance classification - target - gene from which proteins are derived - substance relationship
Y
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 192/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Comment
RI.1 Any comment can be provided in this field, if necessary.
N Text 4000
substance_classification (1..n)
RI.SCLF The substance classification
Y One or more “Substance Classifications” shall be specified.
Domain SCLF.1.CV The domain of the substance classification shall be provided based on a controlled vocabulary. EXAMPLE: Human Pharmaceuticals
CV [Domain]
Y text 250
Substance_Classification
SCLF.2.CV Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture
CV [Substance Class]
Y Text 250 The information provided in this field shall be automatically populated based on the information provided in the Substance_Classification field (COM.2.CV).
Substance_classification_type
SCLF.3.CV The type of the substance shall be provided based on a controlled vocabulary. NOTE: When Substance_Classification=mixture and the substances that are forming the mixture are of the same class, the class of those substances shall
CV [Substance Type] [Specified substance Type]
Y Text 250 When Substance_Classification= Single or mixture, the [Substance Type] CV applies. When Substance_Classification=Specified substance the [Specified Substance Type] CV applies.
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 193/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
be specified in this field. EXAMPLE: two chemicals forming the mixture, specified_classification_type = chemical If the substances that are forming the mixture are of a different class, the value ‘mixture’ shall be specified in this field. EXAMPLE: One polymer combined in a protein, Specified_classification_type =mixture
Substance_classification_code
SCLF.4 The code of the classification type where applicable shall be specified based on a controlled vocabulary.
N alphanumeric
250
subtype (1..n)
SCLF.ST The subtype section Y
Substance_class_subtype
ST.1.CV The sub-type of the classification shall be described based on a controlled vocabulary. EXAMPLE: Vaccine, Herbal, Multiple Substances
CV [Substance subtype]
Y Text 250
reference_source
SCLF.RS The reference source section
Y
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 194/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
(1..n)
This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described.
N/A N text 2500
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 195/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
substance_relationship (0..n)
RI.REL The substance relationship This section shall provide information related to relationship of a substance, where this is applicable.
N
Relationship
REL.1.CV The relationship of a substance shall be defined based on a controlled vocabulary. NOTE: Target and gene elements are not to be specified in this section. EXAMPLE: transporter, metabolic enzyme
CV [relationship type]
Y Text 250
Interaction_type
REL.2.CV The type of interaction shall be specified based on a controlled vocabulary, where applicable. EXAMPLE: covalent
CV [Interaction Type]
N Text 250
Substance_id
REL.3 The substance identifier, for which the relationship is specified, shall be described.
CV [Substance Name]
N Alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 196/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
Substance_name
REL.4 The substance name shall be specified.
CV [Substance Name]
Y text 4000 Mandatory when there is a “substance relationship”
Amount_type
REL.5.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
amount (0..1)
REL.AMT The amount section N
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Low_limit_numer
AMT.2 The lower limit value of the substance shall be specified, where
N Numeric
10
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 197/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
ator_value
available.
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 198/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Measure]
High_limit_numerator_unit_prefix
AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_nu AMT.17 The non numeric value shall be N alpha 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 199/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
meric_value
specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
numeric
reference_source (1..n)
REL.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 200/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
gene (0..n)
RI.GN The gene section This section shall provide a description of the gene in relation to a substance, where applicable. The gene section refers only to gene that is the origin of the substance (protein).
N This section does not apply when Substance_classification_type is equal to chemical, Specified Substance Group 1, Specified Substance Group 2 and Specified substance group 3.
Gene_sequence_origin
GN.1.CV The common name for the organism from which the final gene sequence originated shall be specified based on a controlled vocabulary. NOTE: it applies primarily to proteins.
CV [Organism Name]
N Text 4000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 201/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Gene_id GN.2 The identifier of the gene shall be provided based on a controlled vocabulary. E.g.: YP_299723.1
CV [Gene Name]
N alphanumeric
12
Gene_name
GN.3 The complete name given for a gene shall be provided based on a controlled vocabulary. E.g.: hIL-10 gene
CV [Gene Name]
Y Text 4000
reference_source (1..n)
GN.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source
RS.3.CV The class of the reference source shall be specified based on a
CV
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 202/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
_class controlled vocabulary. EXAMPLE: Regulatory submission
[Source Class]
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
Gene_element (0..n)
RI.GE The gene element section N
Gene_element_type
GE.1.CV The type of the gene element shall be specified based on a controlled vocabulary. EXAMPLE: enhancer, promoter, silencer, terminator
CV [Gene Element Type]
Y Text 250
Gene_element_id
GE.2 The unique identifier for the gene element shall be specified based on a controlled vocabulary.
CV [Substance
N Alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 203/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
Name]
Gene_element_name
GE.3 The specific gene element name shall be described based on a controlled vocabulary.
CV [Substance Name]
Y Text 4000
reference_source (1..n)
GE.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source
RS.2.CV The type of the reference source shall be specified based on a
CV
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 204/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
_type controlled vocabulary. EXAMPLE: INN
[Source]
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
Target (0..n)
RI.TRG The target section This section shall provide information on the target substance. It refers for genes to the target of the protein expressed by that gene. For all the other substances type it
N This section does not apply when Substance_classification_type is equal to Specified Substance Group 1, Specified Substance Group 2 and Specified substance group 3.
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 205/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
refers to the substrate of the substance. EXAMPLE: enzyme, protein/channel, receptor
Target_gene_id
TRG.1 The identifier of the target gene shall be provided.
CV [Target Gene]
N alphanumeric
12
Target_gene_name
TRG.2 The target gene name shall be specified based on a controlled vocabulary. EXAMPLE: single substance, an enzyme type
CV [Target Gene]
Y Text 4000
Interaction_type
TRG.3.CV The type of interaction shall be specified based on a controlled vocabulary. EXAMPLE: Inhibition
CV [Target interaction type]
Y text 250
Target_organism_type
TRG.4.CV The type of target organism shall be specified based on a controlled vocabulary. EXAMPLE: human, viral
CV [Organism type]
N Text 250
Target_type
TRG.5.CV The target type shall be specified based on a controlled vocabulary.
CV [Target
N Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 206/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: enzyme, receptor, membrane
type]
reference_source (1..n)
TRG.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Referenc RS.5 The textual description of the N/A N text 2500
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 207/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
e_source_citation
reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
Structure (0..n)
SING.STR The structure section The structure of the substance shall be described, where applicable
N The structure section is mandatory when Substance_classification_type= chemical, protein, polymer and nucleic acid.
Structural_representation_type
STR.1.CV The type of the structural representation shall be described based on a controlled vocabulary. EXAMPLE: InChI, mol file
CV [Structural Representation Type]
Y Text 250
Structural_representation
STR.2 The structural representation shall be provided. This shall contain only textual and not graphical information. When we enter more than one structural representation, the whole section is repeated (includes stereochemistry, optical activity etc) E.g. for an InChI code this field is populated with the InChI representation.
N/A Y Alphanumeric
4000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 208/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Structural_representation_attachment
STR.3 A copy of the structural representation shall be provided.
N .jpeg
Stereochemistry
STR.4.CV The stereochemistry of the substance shall be described based on a controlled vocabulary.
CV [Stereochemistry]
Y Text 250
Optical_activity
STR.5.CV The optical activity shall be described based on a controlled vocabulary. EXAMPLE: (+), (-), (+/-)
CV [optical activity]
Y CV 250
Molecular_formula
STR.6 The molecular formula shall be provided. The molecular formula shall be specified with all the characters in capital letters.
N/A N Text 2000
Isotope (0..n)
STR.ISO The isotope section The isotope shall be described in this section, where applicable.
N
Nuclide_id
ISO.1 The identifier for each nuclide shall be provided based on a controlled
CV
N alphanume
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 209/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
[Substance Name]
ric
Nuclide_name
ISO.2 The name for the nuclide shall be provided.
CV [Substance Name]
Y Text 4000
Substitution_type
ISO.3.CV The type of substitution shall be described using a controlled vocabulary. Substitution refers to the relationship between the nuclide and the rest of the substance EXAMPLE: specific; non-specific; unknown
CV [Substitution Type]
Y Text 250
polymer (0..1)
SING.POLY The polymer section The characteristics the uniquely
N The section is mandatory if Substance_type_cv = polymer
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 210/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
define a polymer shall be specified in this section.
Polymer_class
POLY.1.CV The class of polymer shall be described based on a controlled vocabulary. EXAMPLE: homopolymer, copolymer
CV [Polymer Class]
Y Text 250
Polymer_geometry
POLY.2.CV The geometry of the polymer shall be described based on a controlled vocabulary. EXAMPLE: linear, branched, cross linked, network, dendritic, star, comb, brush
CV [Geometry]
Y Text 250
Copolymer_sequence_type
POLY.3.CV The type of copolymer of the polymer sequence shall be described based on a controlled vocabulary. EXAMPLE: random, alternating, block, graft, Statistical
CV [Copolymer Sequence Type]
Y Text 250
Comment
POLY.4 Any comment can be provided in this field, if necessary.
N/A N Text 4000
monomer_description
POLY.MDESC The description of the monomer section.
N
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 211/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
(0..n) Number_
of_monomers
MDESC.1 The number of diverse monomers that constitutes the polymer shall be specified.
N/A Y Numeric
4 The value is automatically calculated.
monomer (0..n)
MDESC.MON The monomer section. This section is repeatable for each monomer of the polymer.
Y
Monomer_id
MON.1 The unique identifier assigned to the monomer based on controlled vocabulary.
CV [Substance Name]
N Alphanumeric
12 In the absence of a unique “Substance ID” e.g. for the initial submission of the substance this data element shall not be populated. If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified accordingly.
Monomer_name
MON.2.CV The name of the monomer shall be provided.
CV [Substance Name]
Y Text 4000
Amount_type
MON.3.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 212/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
amount (0..1)
MON.AMT The amount section N
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limi AMT.7.CV The prefix of the lower limit unit of CV N alpha 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 213/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
t_ denominator_unit_prefix
the substance shall be specified, where available.
[Unit Prefix]
numeric
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average AMT.14 The average amount or single value N Nume 10
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 214/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
of the substance shall be specified.
ric
Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
structural_repeat (0..n)
POLY.SR The structural repeat section N This section is mandatory if Number_of_monomers is >1
Number_of_structural_repeat_units
SR.1 The number of diverse repeated units represented in the structure of the polymer shall be specified. The number of time that the monomer is repeated in the polymer. EXAMPLE: PEG 40 is 40
N/A
Y Numeric
4 The value is automatically calculated.
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 215/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
structural_repeat_unit (1..n)
SR.SRU Y
Orientation_of_polymerization
SRU.1.CV The orientation of the polymerization shall be described based on a controlled vocabulary. EXAMPLE: head-tail, head-head, random
CV [Orientation]
Y Text 250
Structural_repeat_unit
SRU.2 The letter that relates back to the structure of the unit shall be specified in order of decreasing molecular weight. EXAMPLE: a,b,c,...
N/A N Text 250
Amount_type
SRU.3.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
amount (1..1)
SRU.AMT The amount section N
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 10
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 216/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
250
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
High_limi AMT.9.CV The higher limit unit of the CV N alpha 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 217/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
t_numerator_unit
substance shall be specified, where available.
[Unit of Measure]
numeric
High_limit_numerator_unit_prefix
AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 218/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Measure]
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
degree_polymerization (1..1)
SRU.DOP The degree of the polymerization section.
Y
Degree_of_polymerization
DOP.1.CV The type of the degree of polymerization shall be described.
CV [Degree of Polymerization]
Y Text 250
Amount_type
DOP.2.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
amount (0..1)
DOP.AMT The amount section N
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 219/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limi AMT.9.CV The higher limit unit of the CV N alpha 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 220/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
t_numerator_unit
substance shall be specified, where available.
[Unit of Measure]
numeric
High_limit_numerator_unit_prefix
AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 221/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Measure]
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
molecular_weight (0..n)
POLY.MWT The molecular weight section N The section is mandatory if Substance_classification_type= protein, polymer or nucleic acid
Molecular_weight_method
MWT.1.CV The method used to measure the molecular weight shall be specified based on a controlled vocabulary. EXAMPLE: sds_page
CV [Method of Measure]
Y text 250
Molecular_weight_type
MWT.2.CV The type of the molecular weight shall be specified based on a controlled vocabulary.
CV [Molecular Weight Type]
Y Text 250
Amount_type
MWT.3.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
Amount (1..1)
MWT.AMT The amount section Y
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 222/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 223/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where
CV
N alphanume
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 224/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
available.
[Unit Prefix]
ric
Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
Property (0..n)
POLY.PROP The property section The characteristics of the property shall be described.
N
Property_type
PROP.1.CV The type of property shall be specified based on a controlled vocabulary. EXAMPLE: physical, chemical, enzymatic, immunological
CV [Property Type]
Y Text 250
Property_name
PROP.2.CV The name of property shall be specified based on a Controlled Vocabulary.
CV [Parameter]
Y Text 250
Substance_id
PROP.3 The identifier of the substance related to a defining property shall
CV
N Alphanume
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 225/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
be described where applicable and based on controlled vocabulary. EXAMPLE: solubility in Water, Water ID shall be specified NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
[Substance Name]
ric
Substance_name
PROP.4 The name of the substance related to a defining property shall be described where applicable. EXAMPLE: solubility in Water, Water shall be specified
CV [Substance Name]
N Text 4000
Amount_type
PROP.5.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
amount (1..1)
PROP.AMT The amount section Y
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 226/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 227/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where
CV
N alphanume
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 228/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
available.
[Unit Prefix]
ric
Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
Modification (0..n)
POLY.MOD The modification section The modification details shall be specified.
N This section apply to: -Nucleic Acid -Protein -Polymer -Structurally Diverse Substances -Mixture This section shall be repeatable to describe each modification occurred on each residue modified.
Modification_type
MOD.1.CV The type of the modification shall be provided based on a controlled vocabulary. EXAMPLE: Structural
CV [Modification Type]
Y Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 229/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Residue_modified
MOD.2.CV The name of the residue modified shall be described based on controlled vocabulary. NOTE: For virus or bacteria the value residue modified is = not applicable;
CV [Nucleotide Bases] OR [Aminoacid] OR [Substance Name]
Y Text 4000 If Substance_classification_type= protein, the CV [Amino acid] applies; If Substance_classification_type= nucleic acid, the CV [Nucleotide Bases] applies; If Substance_classification_type= polymer, the CV [Substance Name] applies. If Substance_classification_type= Structurally Diverse Substance or Mixture, the value residue modified is= not applicable
Residue_site
MOD.3 The position of specific residue undergone to modifications shall be described. Each residue shall be specified followed by a comma and space. For protein and nucleic acid, the number of the subunit followed by the number of the residue modified
N Text 2000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 230/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
shall be specified. The underscore “_” shall be used as separator. EXAMPLE: 1_10 refers to the 10th residue on the 1st subunit Or A1_10
physical_modification (0..n)
MOD.PM The physical modification section N This section shall only apply if Modification_type= Physical
Role PM.1.CV The role of the physical modification shall be provided based on a controlled vocabulary. EXAMPLE: inactivation, activation
CV [Modification]
Y Text 250
Number_of_parameters
PM.2 The number of parameter that is going to be described as result of the modification shall be provided.
No N Numeric
4 The value is automatically calculated.
Parameter (0..n)
PM.PARA The parameter section N The repeatability of this section is strictly related to the Value of the “Number_of_ Parameter” field. The section shall be repeated as many time as specified in the
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 231/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
‘number_of_parameters’ field.
Parameter
PARA.1.CV The parameter shall be described based on controlled vocabulary. EXAMPLE: time, temperature, pressure
CV [Parameter]
Y Text 250
Amount_type
PARA.2.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
amount (0..1)
PARA.AMT The amount section N
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numer
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified,
CV
N alphanumer
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 232/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
ator_unit_prefix
where available.
[Unit Prefix]
ic
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_val
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 233/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
ue
High_limit_ denominator _unit
AMT.12.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
structural_modification
MOD.SM The structural modification section N This section shall apply if Modification_type= Structural
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 234/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
(0..n)
This section is repeatable.
Structural_modification_type
SM.1.CV The type of the structural modification shall be described based on a controlled vocabulary
CV [Modification]
Y Text 250
Moiety (0..n)
SM.MOT The moiety section This section describes the moiety affected by the modification where applicable.
N
Moiety_Role
MOT.1.CV The role of the moiety shall be described based on a controlled vocabulary. EXAMPLE: antigen, linker, conjugate
CV [Role]
Y text 250
Moiety_name
MOT.2 The name of the moiety shall be provided. If the substance name is not present in the Controlled Vocabulary, the moiety name shall be described as a free text.
CV [Substance Name]
Y Text 4000
Moiety_id
MOT.3 The unique identifier assigned to the substance representing the moiety based on controlled vocabulary. NOTE:
CV [Substance Name]
N Alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 235/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
Amount_type
MOT.4.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
amount (0..1)
MOT.AMT The amount section N
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 236/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limi AMT.11 The higher limit value of the N Nume 10
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 237/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
t_denominator_value
substance shall be specified, where available.
ric
High_limit_ denominator _unit
AMT.12.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
molecular_ SM.MFRAG The molecular fragment section. N
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 238/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
fragment (0..n)
This section describes the molecular fragment affected by the modification where applicable.
Role MFRAG.1.CV The role of the molecular fragment shall be described based on a controlled vocabulary.
CV [Role]
Y Text 250
Molecular_fragment_id
MFRAG.2 The unique identifier for molecular fragment shall be provided. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
CV [Substance Name]
N Alphanumeric
12
Molecular_fragment_name
MFRAG.3 The name for molecular fragment shall be specified.
CV [Substance Name]
Y Text 4000
Amount_type
MFRAG.4.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount
N Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 239/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Type]
amount (0..1)
MFRAG.AMT The amount section N
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 240/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 241/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
agent_modification (0..n)
MOD.AM The modification agent section. This section described the agent that caused the modification.
N
Agent_modification_type
AM.1.CV The type of the agent used for the modification shall be specified based on a controlled vocabulary. EXAMPLE: chemical, enzymatic
CV [Agent Modification Type]
Y text 250
Role AM.2.CV The role of the modification agent shall be specified based on a controlled vocabulary.
CV [Modificatio
Y Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 242/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
n]
Modification_agent
AM.3 The name of modifying agent shall be specified based on a controlled vocabulary.
CV [Substance Name]
Y Text 4000
Modification_agent_id
AM.4 The unique identifier of modifying agent shall be provided. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
CV [Substance Name]
N Alphanumeric
12
Modification_process
AM.5.CV The modification process shall be specified based on a controlled vocabulary. EXAMPLE: UV irradiation
CV [Modification Process]
N Text
250
Amount_type
AM.6.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 243/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
amount (0..1)
AM.AMT The amount section N
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified,
CV
N alphanume
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 244/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
denominator_unit_prefix
where available.
[Unit Prefix]
ric
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 245/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
source_material (0..n)
POLY.SRCM The source material section The source material shall be specified in this section.
N
Source_material_class
SRCM.1.CV The classification of the source material shall be specified based on controlled vocabulary. EXAMPLE: organic, inorganic
CV [Source Material Cass]
Y text 250 The source material class values allow the display of different Source_material_type value as specified below.
Source_material_type
SRCM.2.CV The type of the source material shall be specified based on controlled vocabulary. For vaccines this section refers to
CV organism type]
Y text 250 If Source material class= inorganic, the [Inorganic Material Type] CV applies If Source material class =
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 246/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
the class of infectious agent. EXAMPLE: bacterium, human, mammal, fungus, virus, plant
Or [Inorganic Material Type]
organic, CV organism type] applies
Source_material_state
SRCM.3.CV The state of the source material shall be specified based on controlled vocabulary. EXAMPLE: live, activated, inactivated, attenuated, conjugated, live (attenuated).
CV [Source material state]
Y text 250
Organism_id
SRCM.4 The unique identifier associated with the source material parent organism shall be specified.
CV [Organism Name]
N Alphanumeric
12
Organism_name
SRCM.5 The organism accepted Latin name shall be provided based on the binomial Latin nomenclature. The latest version of the Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.
CV [Organism Name]
Y text 4000
Developmental_stage
SRCM.6.CV The developmental stage shall be defined based on a controlled vocabulary. EXAMPLE: foetus, infant, juvenile, adult, senescent, leafing, pre-flowering, flowering, fruiting
CV [Developmental Stage]
N text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 247/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Part (0..n)
SRCM.PT The part section is required to be provided where applicable.
N
Part PT.1.CV The portion of an organism with a definable anatomical location shall be described based on a controlled vocabulary.
CV [Plant Part] Or [Organism Part]
Y Text 250 If Source_material_type= human or mammalian the [organism part] CV applies; If Source_material_type= plant, [Plant Part] CV applies
Part_location
PT.2.CV The anatomical location shall be specified based on a controlled vocabulary. EXAMPLE: Stomach, shoulder
CV [Location]
Y Text 250 Applicable only if Source_material_type= human or mammalian
Fraction (0..n)
SRCM.FRCT The fraction section. Fraction of the part if applicable
N
Material_type
FRCT.1.CV The material type shall be specified based on a controlled vocabulary. EXAMPLE: cell, polysaccharide
CV [Material Type]
Y Text 250
Fraction FRCT.2.CV The fraction shall be specified based on a controlled vocabulary. The fractions of fractions are
CV [Fraction]
N Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 248/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
allowed.
organism (0..n)
SRCM.ORG The organism section The organism shall be defined based on specific elements defined in this section. This section describes the organism which the substance derived from. For vaccines, the parent organism shall be specified based on these section elements. The latest version of the Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.
N
Kingdom ORG.1.CV The kingdom of an organism shall be specified based on a controlled vocabulary.
CV [Kingdom]
N Text 250
Phylum ORG.2.CV The phylum of an organism shall be specified based on a controlled vocabulary.
CV [Phylum]
N Text 250
Class ORG.3.CV The class of an organism shall be specified based on a controlled vocabulary.
CV [Class]
N Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 249/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: Mammalia, maxillopoda, Sauropsida
Order ORG.4.CV The order of an organism shall be specified based on a controlled vocabulary. EXAMPLE: Primate
CV [Order]
N Text 250
Family ORG.5.CV The family of an organism shall be specified based on a controlled vocabulary. EXAMPLE: Homidae
CV [Family]
N Text 250
Genus ORG.6.CV The genus of an organism shall be specified based on a controlled vocabulary. Refers to the Latin epithet of the genus of the plant/animal; it is present in names for genera, species and infraspecies EXAMPLE: Tanacetum
CV [Genus]
Y Text 250
Species ORG.7.CV The species of an organism shall be specified based on a controlled vocabulary. Refers to the Latin epithet of the species of the plant/animal; it is
CV [Species]
Y Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 250/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
present in names for species and infraspecies EXAMPLE: Parthenium
Species_parenthetical_author
ORG.8 The parenthetical author of an organism species shall be specified. Refers to the first author, who published the plant/animal name (of any rank). EXAMPLE: (L.)
N/A N Text 2000
Species_parenthetical_author_year
ORG.9 The parenthetical author year of an organism species an organism shall be specified. Refers to the year in which the first author published the plant/animal name (of any rank). For vaccines names, it refers to the year of isolation. EXAMPLE: 2010/2011
N/A N alphanumeric
10
Species_primary_author
ORG.10 The primary author of an organism species shall be specified. Refers to the first author, who published the plant/animal name (of any rank) EXAMPLE: Sch.Bip
N/A N Text 2000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 251/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Species_primary_author_year
ORG.11 The primary author year of an organism species shall be specified. Refers to the year in which the first author published the plant/animal name (of any rank)
N/A N alphanumeric
10
Hybrid_species_maternal_organism_id
ORG.12 The identifier of the maternal species constituting the hybrid organism shall be specified based on a controlled vocabulary.
CV [Species]
N Alphanumeric
12
Hybrid_species_paternal_organism_id
ORG.13 The identifier of the paternal species constituting the hybrid organism shall be specified based on a controlled vocabulary.
CV [Species]
N Alphanumeric
12
Hybrid_type
ORG.14 The hybrid type of an organism shall be defined.
Yes/No
N Boolean
Infraspecfic_type
ORG.15.CV The infraspecific type of an organism shall be specified based on a controlled vocabulary.
CV [Infraspecific Type]
N Text 250
Infraspec_descripti
ORG.16 The infraspecific description of an organism shall be specified based on a controlled vocabulary. For Influenza Vaccine, the infraspecifc description shall contain
N/A
N Text 4000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 252/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
the syntax of the antigen in line with the WHO convention. EXAMPLE: A/BRISBANE/59/2007(H1N1)
Infraspecific_parenthetical_author
ORG.17 The infraspecific parenthetical author of an organism shall be specified. Refers to the first author, who published the infraspecific plant/animal name (of any rank)
N/A N Text 2000
Infraspecific_parenthetical_author_year
ORG.18 The infraspecific parenthetical author year of an organism shall be specified. Refers to the year in which the first author published the infraspecific plant/animal name (of any rank)
N/A N alphanumeric
10
Infraspecific_primary_author
ORG.19 The infraspecific primary author of an organism shall be specified. Refers to the first author, who published the infraspecific plant/animal name (of any infraspecific rank)
N/A N Text 2000
Infraspecific_primary_auth
ORG.20 The infraspecific primary author year of an organism shall be specified.
N/A N alphanumeric
10
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 253/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
or_year Refers to the year in which the first author published the infraspecific plant/animal name (of any infraspecific rank)
reference_source (1..n)
POLY.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 254/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 255/485
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 256/485
4.3.5. SSI for Structurally Diverse Substances
For substances that can be classified as structurally diverse, the following data elements shall be specified:
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
substance
SUB
Language
SUB.LANG The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German
CV [Language]
Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology). For the purpose of describing “Language”, “T” shall be used. In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 257/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
synonyms.
Substance_id
COM.1 The substance identifier shall be described based on a controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
CV [Substance Name]
N Alphanumeric
12
Substance_Classification
COM.2.CV Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture
CV [Substance Class]
Y Text 250
substance_name (1..n)
COM.SNM The substance name section This section contains the set of elements for the description of the name of the substance.
Y
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 258/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
The latest version of the Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.
Substance_name
SNM.1 The name of the substance shall be specified.
Y Text 4000
Substance_name_type
SNM.2.CV The type of the name shall be specified based on a controlled vocabulary. EXAMPLE: Official name, Code
CV [Substance Name Type]
Y text 250
Language
SNM.3.CV The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German
CV [Language]
Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology).
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 259/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
For the purpose of describing “Language”, “T” shall be used. In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered synonyms.
official_name (0..n)
SNM.ON The official name section N If “Official Name” has been specified in “Substance_Name_Type” this section is mandatory. For any other name type, the section is present as not mandatory.
Official_name_type
ON.1.CV The type of the official name shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Official_name_status
ON.2.CV The status of the code system shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed.
CV [Status]
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 260/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Official_name_status_change_date
ON.3 The change date of the status of the official name shall be specified in line with the ISO 8601 date format, which shall be only entered when name is changed. EXAMPLE: 2011-06-01
ISO 8601 date format
N alphanumeric
10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD
official_name_domain (1..n)
ON.DOM Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have at least one “Official Name Domain”.
Official_name_domain
DOM.1.CV The domain of the name shall be provided based on a controlled vocabulary. EXAMPLE: Human Pharmaceutical
CV [Domain]
Y Text 250
official_name_jurisdiction (1..n)
ON.JUR The jurisdiction of the official name section
Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 261/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
at least one “Official Name Jurisdiction”.
Official_name_jurisdiction
JUR.1.CV The jurisdiction of the official name shall be provided based on ISO 3166-1 alpha-2 codes with two exceptions: EL (not GR) is used to represent Greece, and UK (not GB) is used to represent the United Kingdom. For the European Union EU shall be used.
CV [Country Code]
Y Text 3
reference_source (1..n)
SNM.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Referenc RS.2.CV The type of the reference CV Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 262/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
e_source_type
source shall be specified based on a controlled vocabulary. EXAMPLE: INN
[Source]
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
substance_code
COM.SC The substance code section This section describes the specific code(s) within one or
N
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 263/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
(0..n) more available code system(s) that apply to a substance.
Code SC.1 The specific code (the value) with regard to a referenced code system shall be provided. NOTE: InChI is not considered a code and shall be specified within the structure description.
N/A Y alphanumeric
500
Code_system
SC.2.CV The code system shall be specified based on a controlled vocabulary.
CV [Code System]
Y
Text 250
Code_system_id
SC.3.CV The identifier for the code system shall be provided based on a controlled vocabulary.
CV [Code System]
N alphanumeric
12
Code_system_status
SC.4.CV The status of the code system shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed.
CV [Status]
Y text 250
Code_system_change_da
SC.5 The change date of the code system shall be specified in line with the ISO 8601 date format,
ISO 8601 date format
N alphanumeric
10 This applies only when the code is changed, so it is not
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 264/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
te where applicable. EXAMPLE: 2011-06-01
applicable for initial submission. ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD
Comment
SC.6 Any comment can be provided in this field, if necessary.
N Text 4000
reference_source (1..n)
SC.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Referenc RS.2.CV The type of the reference CV Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 265/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
e_source_type
source shall be specified based on a controlled vocabulary. EXAMPLE: INN
[Source]
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
version (1..n)
COM.VER The version section This section shall provide information on the version of
Y Where no “Version Number” and “Effective Date” have been assigned by an authority
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 266/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
the substance. source, the version number shall be set as 0 with the date set as the date of initial submission of the substance.
Version_number
VER.1 The number of the version of the SSI shall be provided.
N/A Y numeric
4
Effective_date
VER.2 The date when the SSI was effective shall be provided in line with the ISO 8601 date format. This shall be defined when the SSI is generated or modified.
ISO 8601 date format
N alphanumeric
10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD
Change_made
VER.3 The description of the updates or changes of the SSI shall be specified. The field will be left empty when first insert of substance.
N/A
N text 4000
reference_information (1..1)
COM.RI The reference information section This section is used to provide details about:
Y
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 267/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
- substance classification - target - gene from which proteins are derived - substance relationship
Comment
RI.1 Any comment can be provided in this field, if necessary.
N Text 4000
substance classification (1..n)
RI.SCLF The substance classification
Y One or more “Substance Classifications” shall be specified.
Domain SCLF.1.CV The domain of the substance classification shall be provided based on a controlled vocabulary. EXAMPLE: Human Pharmaceuticals
CV [Domain]
Y text 250
Substance_Classification
SCLF.2.CV Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture
CV [Substance Class]
Y Text 250 The information provided in this field shall be automatically populated based on the information provided in the Substance_Classification field (COM.2.CV).
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 268/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Substance_classification_type
SCLF.3.CV The type of the substance shall be provided based on a controlled vocabulary. NOTE: When Substance_Classification=mixture and the substances that are forming the mixture are of the same class, the class of those substances shall be specified in this field. EXAMPLE: two chemicals forming the mixture, specified_classification_type = chemical If the substances that are forming the mixture are of a different class, the value ‘mixture’ shall be specified in this field. EXAMPLE: One polymer combined in a protein, Specified_classification_type =mixture
CV [Substance Type] [Specified substance Type]
Y Text 250 When Substance_Classification= Single or mixture, the [Substance Type] CV applies. When Substance_Classification=Specified substance the [Specified Substance Type] CV applies.
Substance_classification_c
SCLF.4 The code of the classification type where applicable shall be specified based on a controlled
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 269/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
ode vocabulary.
subtype (1..n)
SCLF.ST The subtype section Y
Substance_class_subtype
ST.1.CV The sub-type of the classification shall be described based on a controlled vocabulary. EXAMPLE: Vaccine, Herbal, Multiple Substances
CV [Substance subtype]
Y Text 250
reference_source (1..n)
SCLF.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary.
CV [Source]
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 270/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: INN
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
substance_relationship (0..n)
RI.REL The substance relationship This section shall provide information related to relationship of a substance, where this is applicable.
N
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 271/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Relationship
REL.1.CV The relationship of a substance shall be defined based on a controlled vocabulary. NOTE: Target and gene elements are not to be specified in this section. EXAMPLE: transporter, metabolic enzyme
CV [relationship type]
Y Text 250
Interaction_type
REL.2.CV The type of interaction shall be specified based on a controlled vocabulary, where applicable. EXAMPLE: covalent
CV [Interaction Type]
N Text 250
Substance_id
REL.3 The substance identifier, for which the relationship is specified, shall be described. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique
CV [Substance Name]
N Alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 272/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
“Substance ID” e. g. for the initial submission of the substance this data element is not required.
Substance_name
REL.4 The substance name shall be specified.
CV [Substance Name]
Y text 4000 Mandatory when there is a “substance relationship”
Amount_type
REL.5.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
amount (0..1)
REL.AMT The amount section N
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 273/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Measure]
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 274/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
High_limit_numerator_unit_prefix
AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 275/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
reference_source (1..n)
REL.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source
RS.3.CV The class of the reference source shall be specified based
CV
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 276/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
_class on a controlled vocabulary. EXAMPLE: Regulatory submission
[Source Class]
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
gene (0..n)
RI.GN The gene section This section shall provide a description of the gene in relation to a substance, where applicable. The gene section refers only to gene that is the origin of the substance (protein).
N This section does not apply when Substance_classification_type is equal to chemical, Specified Substance Group 1, Specified Substance Group 2 and Specified substance group 3.
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 277/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Gene_sequence_origin
GN.1.CV The common name for the organism from which the final gene sequence originated shall be specified based on a controlled vocabulary. NOTE: it applies primarily to proteins.
CV [Organism Name]
N Text 2000
Gene_id GN.2 The identifier of the gene shall be provided based on a controlled vocabulary. E.g.: YP_299723.1
CV [Gene Name]
N alphanumeric
12
Gene_name
GN.3 The complete name given for a gene shall be provided based on a controlled vocabulary. E.g.: hIL-10 gene
CV [Gene Name]
Y Text 4000
reference_source (1..n)
GN.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 278/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference:
N/A N text 2500
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 279/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Encycl. 3: 429 (1792)
Gene_element (0..n)
RI.GE The gene element section N
Gene_element_type
GE.1.CV The type of the gene element shall be specified based on a controlled vocabulary. EXAMPLE: enhancer, promoter, silencer, terminator
CV [Gene Element Type]
Y Text 250
Gene_element_id
GE.2 The unique identifier for the gene element shall be specified based on a controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
CV [Substance Name]
N Alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 280/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Gene_element_name
GE.3 The specific gene element name shall be described based on a controlled vocabulary.
CV [Substance Name]
Y Text 4000
reference_source (1..n)
GE.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary.
CV [Source Class]
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 281/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: Regulatory submission
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
Target (0..n)
RI.TRG The target section This section shall provide information on the target substance. It refers for genes to the target of the protein expressed by that gene. For all the other substances type it refers to the substrate of the substance.
N This section does not apply when Substance_classification_type is equal to Specified Substance Group 1, Specified Substance Group 2 and Specified substance group 3.
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 282/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: enzyme, protein/channel, receptor
Target_gene_id
TRG.1 The identifier of the target gene shall be provided.
CV [Target Gene]
N alphanumeric
12
Target_gene_name
TRG.2 The target gene name shall be specified based on a controlled vocabulary. EXAMPLE: single substance, an enzyme type
CV [Target Gene]
Y Text 4000
Interaction_type
TRG.3.CV The type of interaction shall be specified based on a controlled vocabulary. EXAMPLE: Inhibition
CV [Target interaction type]
Y text 250
Target_organism_type
TRG.4.CV The type of target organism shall be specified based on a controlled vocabulary. EXAMPLE: human, viral
CV [Organism type]
N Text 250
Target_type
TRG.5.CV The target type shall be specified based on a controlled vocabulary.
CV [Target type]
N Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 283/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: enzyme, receptor, membrane
reference_source (1..n)
TRG.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Referenc RS.4 The code or number referring N/A N alpha 12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 284/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
e_source_id
to the reference source shall be specified.
numeric
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
Structure (0..n)
SING.STR The structure section The structure of the substance shall be described, where applicable
N The structure section is mandatory when Substance_classification_type= chemical, protein, polymer and nucleic acid.
Structural_representation_type
STR.1.CV The type of the structural representation shall be described based on a controlled vocabulary. EXAMPLE: InChI, mol file
CV [Structural Representation Type]
Y Text 250
Structural_representation
STR.2 The structural representation shall be provided. This shall contain only textual and not graphical information.
N/A Y Alphanumeric
4000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 285/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
When we enter more than one structural representation, the whole section is repeated (includes stereochemistry, optical activity etc) E.g. for an InChI code this field is populated with the InChI representation.
Structural_representation_attachment
STR.3 A copy of the structural representation shall be provided.
N .jpeg
Stereochemistry
STR.4.CV The stereochemistry of the substance shall be described based on a controlled vocabulary.
CV [Stereochemistry]
Y Text 250
Optical_activity
STR.5.CV The optical activity shall be described based on a controlled vocabulary. EXAMPLE: (+), (-), (+/-)
CV [optical activity]
Y CV 250
Molecular_formul
STR.6 The molecular formula shall be provided.
N/A N Text 2000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 286/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
a The molecular formula shall be specified with all the characters in capital letters.
Isotope (0..n)
STR.ISO The isotope section The isotope shall be described in this section, where applicable.
N
Nuclide_id
ISO.1 The identifier for each nuclide shall be provided based on a controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
CV [Substance Name]
N alphanumeric
12
Nuclide_name
ISO.2 The name for the nuclide shall be provided.
CV
Y Text 4000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 287/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
[Substance Name]
Substitution_type
ISO.3.CV The type of substitution shall be described using a controlled vocabulary. Substitution refers to the relationship between the nuclide and the rest of the substance EXAMPLE: specific; non-specific; unknown
CV [Substitution Type]
Y Text 250
structurally_Diverse_Substance (0..1)
SING.SD The structurally diverse substance section The identifying characteristics of the structurally diverse substances shall be specified.
Comment
SD.1 Any comment can be provided in this field, if necessary.
Modification (0..n)
SD.MOD The modification section The modification details shall be specified.
N This section apply to: -Nucleic Acid -Protein -Polymer -Structurally Diverse Substances
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 288/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
-Mixture This section shall be repeatable to describe each modification occurred on each residue modified.
Modification_type
MOD.1.CV The type of the modification shall be provided based on a controlled vocabulary. EXAMPLE: Structural
CV [Modification Type]
Y Text 250
Residue_modified
MOD.2.CV The name of the residue modified shall be described based on controlled vocabulary. NOTE: For virus or bacteria the value residue modified is = not applicable;
CV [Nucleotide Bases] OR [Aminoacid] OR [Substance Name]
Y Text 4000 If Substance_classification_type= protein, the CV [Aminoacid] applies; If Substance_classification_type= nucleic acid, the CV [Nucleotide Bases] applies; If Substance_classification_type= polymer, the CV [Substance Name] applies.
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 289/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
If Substance_classification_type= Structurally Diverse Substance or Mixture, the value residue modified is= not applicable
Residue_site
MOD.3 The position of specific residue undergone to modifications shall be described. Each residue shall be specified followed by a comma and space. For protein and nucleic acid, the number of the subunit followed by the number of the residue modified shall be specified. The underscore “_” shall be used as separator. EXAMPLE: 1_10 refers to the 10th residue on the 1st subunit Or A1_10
N Text 2000
physical_ MOD.PM The physical modification N This section shall only apply if
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 290/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
modification (0..n)
section Modification_type= Physical
Role PM.1.CV The role of the physical modification shall be provided based on a controlled vocabulary. EXAMPLE: inactivation, activation
CV [Modification]
Y Text 250
Number_of_parameters
PM.2 The number of parameter that is going to be described as result of the modification shall be provided.
No N Numeric
4 The value is automatically calculated.
Parameter (0..n)
PM.PARA The parameter section N The repeatability of this section is strictly related to the Value of the “Number_of_ Parameter” field. The section shall be repeated as many time as specified in the ‘number_of_parameters’ field.
Parameter
PARA.1.CV The parameter shall be described based on controlled vocabulary. EXAMPLE: time, temperature,
CV [Parameter]
Y Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 291/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
pressure
Amount_type
PARA.2.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
amount (0..1)
PARA.AMT The amount section N
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denomi
AMT.5 The lower limit value of the substance shall be specified,
N Numeric
10
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 292/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
nator_value
where available.
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 293/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
High_limit_ denominator _unit
AMT.12.CV
The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV
The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV
The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 294/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
structural_modification (0..n)
MOD.SM The structural modification section
N This section shall apply if Modification_type= Structural This section is repeatable.
Structural_modification_type
SM.1.CV The type of the structural modification shall be described based on a controlled vocabulary
CV [Modification]
Y Text 250
Moiety (0..n)
SM.MOT The moiety section This section describes the moiety affected by the modification where applicable.
N
Moiety_Role
MOT.1.CV The role of the moiety shall be described based on a controlled vocabulary. EXAMPLE: antigen, linker, conjugate
CV [Role]
Y text 250
Moiety_name
MOT.2 The name of the moiety shall be provided. If the substance name is not present in the Controlled Vocabulary, the moiety name
CV [Substance Name]
Y Text 4000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 295/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
shall be described as a free text.
Moiety_id
MOT.3 The unique identifier assigned to the substance representing the moiety based on controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
CV [Substance Name]
N Alphanumeric
12
Amount_type
MOT.4.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
amount (0..1)
MOT.AMT The amount section N
Quantity AMT.1.CV CV N text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 296/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Operator [Quantity Operator]
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 297/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV
The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 298/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Prefix AMT.15.CV
The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV
The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
molecular_fragment (0..n)
SM.MFRAG The molecular fragment section. This section describes the molecular fragment affected by the modification where applicable.
N
Role MFRAG.1.CV
The role of the molecular fragment shall be described based on a controlled vocabulary.
CV [Role]
Y Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 299/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Molecular_fragment_id
MFRAG.2 The unique identifier for molecular fragment shall be provided. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
CV [Substance Name]
N Alphanumeric
12
Molecular_fragment_name
MFRAG.3 The name for molecular fragment shall be specified.
CV [Substance Name]
Y Text 4000
Amount_type
MFRAG.4.CV
The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
amount
MFRAG.AMT
The amount section N
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 300/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
(0..1)
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_
AMT.7.CV The prefix of the lower limit unit of the substance shall be
CV
N alphanume
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 301/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
denominator_unit_prefix
specified, where available.
[Unit Prefix] ric
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV
The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 302/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV
The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV
The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
agent_modification (0..n)
MOD.AM The modification agent section. This section described the agent that caused the modification.
N
Agent_modification_type
AM.1.CV The type of the agent used for the modification shall be specified based on a controlled vocabulary.
CV [Agent Modification
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 303/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: chemical, enzymatic
Type]
Role AM.2.CV The role of the modification agent shall be specified based on a controlled vocabulary.
CV [Modification]
Y Text 250
Modification_agent
AM.3 The name of modifying agent shall be specified based on a controlled vocabulary.
CV [Substance Name]
Y Text 4000
Modification_agent_id
AM.4 The unique identifier of modifying agent shall be provided. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
CV [Substance Name]
N Alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 304/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Modification_process
AM.5.CV The modification process shall be specified based on a controlled vocabulary. EXAMPLE: UV irradiation
CV [Modification Process]
N Text
250
Amount_type
AM.6.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
amount (0..1)
AM.AMT The amount section N
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerator_unit
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 305/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
_prefix
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limi AMT.11 The higher limit value of the N Nume 10
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 306/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
t_denominator_value
substance shall be specified, where available.
ric
High_limit_ denominator _unit
AMT.12.CV
The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV
The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV
The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable.
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 307/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: Short, High (temperature)
Property (0..n)
SD.PROP The property section The characteristics of the property shall be described.
N
Property_type
PROP.1.CV
The type of property shall be specified based on a controlled vocabulary. EXAMPLE: physical, chemical, enzymatic, immunological
CV [Property Type]
Y Text 250
Property_name
PROP.2.CV
The name of property shall be specified based on a Controlled Vocabulary.
CV [Parameter]
Y Text 250
Substance_id
PROP.3 The identifier of the substance related to a defining property shall be described where applicable and based on controlled vocabulary. EXAMPLE: solubility in Water, Water ID shall be specified NOTE: If a unique “Substance ID”
CV [Substance Name]
N Alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 308/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
(EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
Substance_name
PROP.4 The name of the substance related to a defining property shall be described where applicable. EXAMPLE: solubility in Water, Water shall be specified
CV [Substance Name]
N Text 4000
Amount_type
PROP.5.CV
The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
amount (1..1)
PROP.AMT The amount section Y
Quantity Operator
AMT.1.CV CV
N text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 309/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
[Quantity Operator]
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 310/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV
The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 311/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Prefix AMT.15.CV
The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV
The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
source_material (0..n)
SD.SRCM The source material section The source material shall be specified in this section.
N
Source_material_class
SRCM.1.CV
The classification of the source material shall be specified based on controlled vocabulary. EXAMPLE: organic, inorganic
CV [Source Material Cass]
Y text 250 The source material class values allow the display of different Source_material_type value as specified below.
Source_material
SRCM.2.CV
The type of the source material shall be specified based on
CV
Y text 250 If Source material class= inorganic, the [Inorganic
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 312/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
_type controlled vocabulary. For vaccines this section refers to the class of infectious agent. EXAMPLE: bacterium, human, mammal, fungus, virus, plant
organism type] Or [Inorganic Material Type]
Material Type] CV applies If Source material class = organic, CV organism type] applies
Source_material_state
SRCM.3.CV
The state of the source material shall be specified based on controlled vocabulary. EXAMPLE: live, activated, inactivated, attenuated, conjugated, live (attenuated).
CV [Source material state]
Y text 250
Organism _id
SRCM.4 The unique identifier associated with the source material parent organism shall be specified.
CV [Organism Name]
N Alphanumeric
12
Organism_name
SRCM.5 The organism accepted Latin name shall be provided based on the binomial Latin nomenclature. The latest version of the Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.
CV [Organism Name]
Y text 4000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 313/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Developmental_stage
SRCM.6.CV
The developmental stage shall be defined based on a controlled vocabulary. EXAMPLE: foetus, infant, juvenile, adult, senescent, leafing, pre-flowering, flowering, fruiting
CV [Developmental Stage]
N text 250
Part (0..n)
SRCM.PT The part section is required to be provided where applicable.
N
Part PT.1.CV The portion of an organism with a definable anatomical location shall be described based on a controlled vocabulary.
CV [Plant Part] Or [Organism Part]
Y Text 250 If Source_material_type= human or mammalian the [organism part] CV applies; If Source_material_type= plant, [Plant Part] CV applies
Part_location
PT.2.CV The anatomical location shall be specified based on a controlled vocabulary. EXAMPLE: Stomach, shoulder
CV [Location]
Y Text 250 Applicable only if Source_material_type= human or mammalian
Fraction
SRCM.FRCT
The fraction section.
N
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 314/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
(0..n) Fraction of the part if applicable
Material_type
FRCT.1.CV The material type shall be specified based on a controlled vocabulary. EXAMPLE: cell, polysaccharide
CV [Material Type]
Y Text 250
Fraction FRCT.2.CV The fraction shall be specified based on a controlled vocabulary. The fractions of fractions are allowed.
CV [Fraction]
N Text 250
organism (0..n)
SRCM.ORG
The organism section The organism shall be defined based on specific elements defined in this section. This section describes the organism which the substance derived from. For vaccines, the parent organism shall be specified based on these section elements. The latest version of the
N
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 315/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.
Kingdom ORG.1.CV The kingdom of an organism shall be specified based on a controlled vocabulary.
CV [Kingdom]
N Text 250
Phylum ORG.2.CV The phylum of an organism shall be specified based on a controlled vocabulary.
CV [Phylum]
N Text 250
Class ORG.3.CV The class of an organism shall be specified based on a controlled vocabulary. EXAMPLE: Mammalia, maxillopoda, Sauropsida
CV [Class]
N Text 250
Order ORG.4.CV The order of an organism shall be specified based on a controlled vocabulary. EXAMPLE: Primate
CV [Order]
N Text 250
Family ORG.5.CV The family of an organism shall be specified based on a controlled vocabulary. EXAMPLE: Homidae
CV [Family]
N Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 316/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Genus ORG.6.CV The genus of an organism shall be specified based on a controlled vocabulary. Refers to the Latin epithet of the genus of the plant/animal; it is present in names for genera, species and infraspecies EXAMPLE: Tanacetum
CV [Genus]
Y Text 250
Species ORG.7.CV The species of an organism shall be specified based on a controlled vocabulary. Refers to the Latin epithet of the species of the plant/animal; it is present in names for species and infraspecies EXAMPLE: Parthenium
CV [Species]
Y Text 250
Species_parenthetical_author
ORG.8 The parenthetical author of an organism species shall be specified. Refers to the first author, who published the plant/animal name (of any rank).
N/A N Text 2000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 317/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: (L.)
Species_parenthetical_author_year
ORG.9 The parenthetical author year of an organism species an organism shall be specified. Refers to the year in which the first author published the plant/animal name (of any rank). For vaccines names, it refers to the year of isolation. EXAMPLE: 2010/2011
N/A N alphanumeric
10
Species_primary_author
ORG.10 The primary author of an organism species shall be specified. Refers to the first author, who published the plant/animal name (of any rank) EXAMPLE: Sch.Bip
N/A N Text 2000
Species_primary_author_year
ORG.11 The primary author year of an organism species shall be specified.
N/A N alphanumeric
10
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 318/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Refers to the year in which the first author published the plant/animal name (of any rank)
Hybrid_species_maternal_organism_id
ORG.12 The identifier of the maternal species constituting the hybrid organism shall be specified based on a controlled vocabulary.
CV [Species]
N Alphanumeric
12
Hybrid_species_paternal_organism_id
ORG.13 The identifier of the paternal species constituting the hybrid organism shall be specified based on a controlled vocabulary.
CV [Species]
N Alphanumeric
12
Hybrid_type
ORG.14 The hybrid type of an organism shall be defined.
Yes/No
N Boolean
Infraspecfic_type
ORG.15.CV
The infraspecific type of an organism shall be specified based on a controlled vocabulary.
CV [Infraspecific Type]
N Text 250
Infraspec_descripti
ORG.16 The infraspecific description of an organism shall be specified based on a controlled vocabulary.
N/A
N Text 4000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 319/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
For Influenza Vaccine, the infraspecifc description shall contain the syntax of the antigen in line with the WHO convention. EXAMPLE: A/BRISBANE/59/2007(H1N1)
Infraspecific_parenthetical_author
ORG.17 The infraspecific parenthetical author of an organism shall be specified. Refers to the first author, who published the infraspecific plant/animal name (of any rank)
N/A N Text 2000
Infraspecific_parenthetical_author_year
ORG.18 The infraspecific parenthetical author year of an organism shall be specified. Refers to the year in which the first author published the infraspecific plant/animal name (of any rank)
N/A N alphanumeric
10
Infraspecific_prim
ORG.19 The infraspecific primary author of an organism shall be
N/A N Text 2000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 320/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
ary_author
specified. Refers to the first author, who published the infraspecific plant/animal name (of any infraspecific rank)
Infraspecific_primary_author_year
ORG.20 The infraspecific primary author year of an organism shall be specified. Refers to the year in which the first author published the infraspecific plant/animal name (of any infraspecific rank)
N/A N alphanumeric
10
glycosylation (0..n)
SD.GLY The glycosilation section Details on the glycosilation shall be provided. The section is repeatable to allow the description of each glycosilation present in a protein.
N This section applies if the protein is glycosylated. The value of Glycosylation_type cannot be null. In case of no glycosilation the user must specify the value= Not applicable from the [Glycosylation Type] CV.
Glycosylation_type
GLY.1.CV The type of the glycosilation shall be specified based on a controlled vocabulary.
CV [Glycosylation
Y Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 321/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: human
Type]
N_glycosylation
GLY.2 The site of n-glycosylation shall be described according to the protein sequence. The extent and type of the modification at a given site is not captured. The convention to be used is as follow: “3 Aminoacid code letter+subunit number”_”position of aminoacid” EXAMPLE: asparagine “Asn1_34”
N/A N Alphanumeric
4000 If Glycosylation_type = Not applicable, this field is not applicable.
O_glycosylation
GLY.3 The site of the o-glycosylation shall be described. The convention to be used is as follow: “3 Aminoacid code letter+subunit number”_”position of aminoacid”
N/A N Alphanumeric
4000 If Glycosylation_type = Not applicable, this field is not applicable.
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 322/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: serine “Ser2_34”
C_glycosylation
GLY.4 The site of the c-glycosylation shall be described. The convention to be used is as follow: “3 Aminoacid code letter+subunit number”_”position of aminoacid” EXAMPLE: tryptophan “Trp2_45”
N/A N Alphanumeric
4000 If Glycosylation_type = Not applicable, this field is not applicable.
molecular_weight (0..n)
SD.MWT The molecular weight section N The section is mandatory if Substance_classification_type= protein, polymer or nucleic acid
Molecular_weight_method
MWT.1.CV The method used to measure the molecular weight shall be specified based on a controlled vocabulary. EXAMPLE: sds_page
CV [Method of Measure]
Y text 250
Molecular_weight_type
MWT.2.CV The type of the molecular weight shall be specified based on a controlled vocabulary.
CV [Molecular Weight Type]
Y Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 323/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Amount_type
MWT.3.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
amount (1..1)
MW.AMT The amount section Y
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 324/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denomin
AMT.12.CV
The higher limit unit of the substance shall be specified, where available.
CV [Unit of
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 325/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
ator _unit
Measure]
High_limit_ denominator_unit_prefix
AMT.13.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV
The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV
The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
reference_source
SD.RS The reference source section This section describes the
Y
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 326/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
(1..n) reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source
RS.5 The textual description of the reference source within the
N/A N text 2500
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 327/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
_citation literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 328/485
4.3.6. SSI for Mixtures
For substances that can be classified as a mixture substance, the following data elements shall be specified:
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
substance
SUB
Language
SUB.LANG The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German
CV [Language]
Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology). For the purpose of describing “Language”, “T” shall be used. In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 329/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
synonyms.
Substance_id
COM.1 The substance identifier shall be described based on a controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
CV [Substance Name]
N Alphanumeric
12
Substance_Classification
COM.2.CV Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture
CV [Substance Class]
Y Text 250
substance_name (1..n)
COM.SNM The substance name section This section contains the set of elements for the description of the name of the substance.
Y
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 330/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
The latest version of the Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.
Substance_name
SNM.1 The name of the substance shall be specified.
Y Text 4000
Substance_name_type
SNM.2.CV The type of the name shall be specified based on a controlled vocabulary. EXAMPLE: Official name, Code
CV [Substance Name Type]
Y text 250
Language
SNM.3.CV The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German
CV [Language]
Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology).
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 331/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
For the purpose of describing “Language”, “T” shall be used. In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered synonyms.
official_name (0..n)
SNM.ON The official name section N If “Official Name” has been specified in “Substance_Name_Type” this section is mandatory. For any other name type, the section is present as not mandatory.
Official_name_type
ON.1.CV The type of the official name shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Official_name_status
ON.2.CV The status of the code system shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed.
CV [Status]
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 332/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Official_name_status_change_date
ON.3 The change date of the status of the official name shall be specified in line with the ISO 8601 date format, which shall be only entered when name is changed. EXAMPLE: 2011-06-01
ISO 8601 date format
N alphanumeric
10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD
official_name_domain (1..n)
ON.DOM Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have at least one “Official Name Domain”.
Official_name_domain
DOM.1.CV The domain of the name shall be provided based on a controlled vocabulary. EXAMPLE: Human Pharmaceutical
CV [Domain]
Y Text 250
official_name_jurisdiction (1..n)
ON.JUR The jurisdiction of the official name section
Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 333/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
at least one “Official Name Jurisdiction”.
Official_name_jurisdiction
JUR.1.CV The jurisdiction of the official name shall be provided based on ISO 3166-1 alpha-2 codes with two exceptions: EL (not GR) is used to represent Greece, and UK (not GB) is used to represent the United Kingdom. For the European Union EU shall be used.
CV [Country Code]
Y Text 3
reference_source (1..n)
SNM.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Referenc RS.2.CV The type of the reference CV Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 334/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
e_source_type
source shall be specified based on a controlled vocabulary. EXAMPLE: INN
[Source]
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
substance_code
COM.SC The substance code section This section describes the specific code(s) within one or
N
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 335/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
(0..n) more available code system(s) that apply to a substance.
Code SC.1 The specific code (the value) with regard to a referenced code system shall be provided. NOTE: InChI is not considered a code and shall be specified within the structure description.
N/A Y alphanumeric
500
Code_system
SC.2.CV The code system shall be specified based on a controlled vocabulary.
CV [Code System]
Y
Text 250
Code_system_id
SC.3.CV The identifier for the code system shall be provided based on a controlled vocabulary.
CV [Code System]
N alphanumeric
12
Code_system_status
SC.4.CV The status of the code system shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed.
CV [Status]
Y text 250
Code_system_change_dat
SC.5 The change date of the code system shall be specified in line with the ISO 8601 date format,
ISO 8601 date format
N alphanumeric
10 This applies only when the code is changed, so it is not
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 336/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
e where applicable. EXAMPLE: 2011-06-01
applicable for initial submission. ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD
Comment
SC.6 Any comment can be provided in this field, if necessary.
N Text 4000
reference_source (1..n)
SC.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Referenc RS.2.CV The type of the reference CV Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 337/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
e_source_type
source shall be specified based on a controlled vocabulary. EXAMPLE: INN
[Source]
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
version (1..n)
COM.VER The version section This section shall provide information on the version of
Y Where no “Version Number” and “Effective Date” have been assigned by an authority source,
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 338/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
the substance. the version number shall be set as 0 with the date set as the date of initial submission of the substance.
Version_number
VER.1 The number of the version of the SSI shall be provided.
N/A Y numeric
4
Effective_date
VER.2 The date when the SSI was effective shall be provided in line with the ISO 8601 date format. This shall be defined when the SSI is generated or modified.
ISO 8601 date format
N alphanumeric
10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD
Change_made
VER.3 The description of the updates or changes of the SSI shall be specified. The field will be left empty when first insert of substance.
N/A
N text 4000
reference_information (1..1)
COM.RI The reference information section This section is used to provide details about:
Y
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 339/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
- substance classification - target - gene from which proteins are derived - substance relationship
Comment
RI.1 Any comment can be provided in this field, if necessary.
N Text 4000
substance_classification (1..n)
RI.SCLF The substance classification
Y One or more “Substance Classifications” shall be specified.
Domain SCLF.1.CV The domain of the substance classification shall be provided based on a controlled vocabulary. EXAMPLE: Human Pharmaceuticals
CV [Domain]
Y text 250
Substance_Classification
SCLF.2.CV Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture
CV [Substance Class]
Y Text 250 The information provided in this field shall be automatically populated based on the information provided in the Substance_Classification field (COM.2.CV).
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 340/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Substance_classification_type
SCLF.3.CV The type of the substance shall be provided based on a controlled vocabulary. NOTE: When Substance_Classification=mixture and the substances that are forming the mixture are of the same class, the class of those substances shall be specified in this field. EXAMPLE: two chemicals forming the mixture, specified_classification_type = chemical If the substances that are forming the mixture are of a different class, the value ‘mixture’ shall be specified in this field. EXAMPLE: One polymer combined in a protein, Specified_classification_type =mixture
CV [Substance Type] [Specified substance Type]
Y Text 250 When Substance_Classification= Single or mixture, the [Substance Type] CV applies. When Substance_Classification=Specified substance the [Specified Substance Type] CV applies.
Substance_classification_c
SCLF.4 The code of the classification type where applicable shall be specified based on a controlled
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 341/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
ode vocabulary.
subtype (1..n)
SCLF.ST The subtype section Y
Substance_class_subtype
ST.1.CV The sub-type of the classification shall be described based on a controlled vocabulary. EXAMPLE: Vaccine, Herbal, Multiple Substances
CV [Substance subtype]
Y Text 250
reference_source (1..n)
SCLF.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary.
CV [Source]
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 342/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: INN
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
substance_relationship (0..n)
RI.REL The substance relationship This section shall provide information related to relationship of a substance, where this is applicable.
N
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 343/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Relationship
REL.1.CV The relationship of a substance shall be defined based on a controlled vocabulary. NOTE: Target and gene elements are not to be specified in this section. EXAMPLE: transporter, metabolic enzyme
CV [relationship type]
Y Text 250
Interaction_type
REL.2.CV The type of interaction shall be specified based on a controlled vocabulary, where applicable. EXAMPLE: covalent
CV [Interaction Type]
N Text 250
Substance_id
REL.3 The substance identifier, for which the relationship is specified, shall be described. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique
CV [Substance Name]
N Alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 344/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
“Substance ID” e. g. for the initial submission of the substance this data element is not required.
Substance_name
REL.4 The substance name shall be specified.
CV [Substance Name]
Y text 4000 Mandatory when there is a “substance relationship”
Amount_type
REL.5.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
amount (0..1)
REL.AMT The amount section N
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 345/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Measure]
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 346/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
High_limit_numerator_unit_prefix
AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 347/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
reference_source (1..n)
REL.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source
RS.3.CV The class of the reference source shall be specified based
CV
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 348/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
_class on a controlled vocabulary. EXAMPLE: Regulatory submission
[Source Class]
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
gene (0..n)
RI.GN The gene section This section shall provide a description of the gene in relation to a substance, where applicable. The gene section refers only to gene that is the origin of the substance (protein).
N This section does not apply when Substance_classification_type is equal to chemical, Specified Substance Group 1, Specified Substance Group 2 and Specified substance group 3.
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 349/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Gene_sequence_origin
GN.1.CV The common name for the organism from which the final gene sequence originated shall be specified based on a controlled vocabulary. NOTE: it applies primarily to proteins.
CV [Organism Name]
N Text 2000
Gene_id GN.2 The identifier of the gene shall be provided based on a controlled vocabulary. E.g.: YP_299723.1
CV [Gene Name]
N alphanumeric
12
Gene_name
GN.3 The complete name given for a gene shall be provided based on a controlled vocabulary. E.g.: hIL-10 gene
CV [Gene Name]
Y Text 4000
reference_source (1..n)
GN.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 350/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference:
N/A N text 2500
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 351/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Encycl. 3: 429 (1792)
Gene_element (0..n)
RI.GE The gene element section N
Gene_element_type
GE.1.CV The type of the gene element shall be specified based on a controlled vocabulary. EXAMPLE: enhancer, promoter, silencer, terminator
CV [Gene Element Type]
Y Text 250
Gene_element_id
GE.2 The unique identifier for the gene element shall be specified based on a controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
CV [Substance Name]
N Alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 352/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Gene_element_name
GE.3 The specific gene element name shall be described based on a controlled vocabulary.
CV [Substance Name]
Y Text 4000
reference_source (1..n)
GE.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary.
CV [Source Class]
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 353/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: Regulatory submission
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
Target (0..n)
RI.TRG The target section This section shall provide information on the target substance. It refers for genes to the target of the protein expressed by that gene. For all the other substances type it refers to the substrate of the substance.
N This section does not apply when Substance_classification_type is equal to Specified Substance Group 1, Specified Substance Group 2 and Specified substance group 3.
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 354/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: enzyme, protein/channel, receptor
Target_gene_id
TRG.1 The identifier of the target gene shall be provided.
CV [Target Gene]
N alphanumeric
12
Target_gene_name
TRG.2 The target gene name shall be specified based on a controlled vocabulary. EXAMPLE: single substance, an enzyme type
CV [Target Gene]
Y Text 4000
Interaction_type
TRG.3.CV The type of interaction shall be specified based on a controlled vocabulary. EXAMPLE: Inhibition
CV [Target interaction type]
Y text 250
Target_organism_type
TRG.4.CV The type of target organism shall be specified based on a controlled vocabulary. EXAMPLE: human, viral
CV [Organism type]
N Text 250
Target_type
TRG.5.CV The target type shall be specified based on a controlled vocabulary.
CV [Target type]
N Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 355/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: enzyme, receptor, membrane
reference_source (1..n)
TRG.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Referenc RS.4 The code or number referring to N/A N alpha 12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 356/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
e_source_id
the reference source shall be specified.
numeric
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
mixture_substance (0..1)
EXT.MIXT The mixture substance section The identifying characteristics for a mixture substance shall be described.
The section is mandatory if Substance_type_cv = Mixture
Mixture_type
MIXT.1.CV The type of the mixture shall be specified based on a controlled vocabulary. EXAMPLE: one of, all of, any of
CV [Mixture Type]
Y Text 250
source_material (0..n)
MIXT.SRCM
The source material section The source material shall be specified in this section.
N
Source_ SRCM.1.C The classification of the source CV Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 357/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
material_class
V material shall be specified based on controlled vocabulary. EXAMPLE: organic, inorganic
[Source Material Cass]
The source material class values allow the display of different Source_material_type value as specified below.
Source_material_type
SRCM.2.CV
The type of the source material shall be specified based on controlled vocabulary. For vaccines this section refers to the class of infectious agent. EXAMPLE: bacterium, human, mammal, fungus, virus, plant
CV organism type] Or [Inorganic Material Type]
Y text 250 If Source material class= inorganic, the [Inorganic Material Type] CV applies If Source material class = organic, CV organism type] applies
Source_material_state
SRCM.3.CV
The state of the source material shall be specified based on controlled vocabulary. EXAMPLE: live, activated, inactivated, attenuated, conjugated, live (attenuated).
CV [Source material state]
Y text 250
Organism _id
SRCM.4 The unique identifier associated with the source material parent organism shall be specified.
CV [Organism Name]
N Alphanumeric
12
Organism_name
SRCM.5 The organism accepted Latin name shall be provided based on the binomial Latin
CV [Organism
Y text 4000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 358/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
nomenclature. The latest version of the Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.
Name]
Developmental_stage
SRCM.6.CV
The developmental stage shall be defined based on a controlled vocabulary. EXAMPLE: foetus, infant, juvenile, adult, senescent, leafing, pre-flowering, flowering, fruiting
CV [Developmental Stage]
N text 250
Part (0..n)
SRCM.PT The part section is required to be provided where applicable.
N
Part PT.1.CV The portion of an organism with a definable anatomical location shall be described based on a controlled vocabulary.
CV [Plant Part] Or [Organism Part]
Y Text 250 If Source_material_type= human or mammalian the [organism part] CV applies; If Source_material_type= plant, [Plant Part] CV applies
Part_loca PT.2.CV The anatomical location shall be CV Y Text 250 Applicable only if
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 359/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
tion specified based on a controlled vocabulary. EXAMPLE: Stomach, shoulder
[Location]
Source_material_type= human or mammalian
Fraction (0..n)
SRCM.FRCT
The fraction section. Fraction of the part if applicable
N
Material_type
FRCT.1.CV The material type shall be specified based on a controlled vocabulary. EXAMPLE: cell, polysaccharide
CV [Material Type]
Y Text 250
Fraction FRCT.2.CV The fraction shall be specified based on a controlled vocabulary. The fractions of fractions are allowed.
CV [Fraction]
N Text 250
organism (0..n)
SRCM.ORG
The organism section The organism shall be defined based on specific elements defined in this section. This section describes the organism which the substance
N
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 360/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
derived from. For vaccines, the parent organism shall be specified based on these section elements. The latest version of the Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.
Kingdom ORG.1.CV The kingdom of an organism shall be specified based on a controlled vocabulary.
CV [Kingdom]
N Text 250
Phylum ORG.2.CV The phylum of an organism shall be specified based on a controlled vocabulary.
CV [Phylum]
N Text 250
Class ORG.3.CV The class of an organism shall be specified based on a controlled vocabulary. EXAMPLE: Mammalia, maxillopoda, Sauropsida
CV [Class]
N Text 250
Order ORG.4.CV The order of an organism shall be specified based on a controlled vocabulary.
CV [Order]
N Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 361/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: Primate
Family ORG.5.CV The family of an organism shall be specified based on a controlled vocabulary. EXAMPLE: Homidae
CV [Family]
N Text 250
Genus ORG.6.CV The genus of an organism shall be specified based on a controlled vocabulary. Refers to the Latin epithet of the genus of the plant/animal; it is present in names for genera, species and infraspecies EXAMPLE: Tanacetum
CV [Genus]
Y Text 250
Species ORG.7.CV The species of an organism shall be specified based on a controlled vocabulary. Refers to the Latin epithet of the species of the plant/animal; it is present in names for species and infraspecies
CV [Species]
Y Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 362/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: Parthenium
Species_parenthetical_author
ORG.8 The parenthetical author of an organism species shall be specified. Refers to the first author, who published the plant/animal name (of any rank). EXAMPLE: (L.)
N/A N Text 2000
Species_parenthetical_author_year
ORG.9 The parenthetical author year of an organism species an organism shall be specified. Refers to the year in which the first author published the plant/animal name (of any rank). For vaccines names, it refers to the year of isolation. EXAMPLE: 2010/2011
N/A N alphanumeric
10
Species_primary_author
ORG.10 The primary author of an organism species shall be specified. Refers to the first author, who
N/A N Text 2000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 363/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
published the plant/animal name (of any rank) EXAMPLE: Sch.Bip
Species_primary_author_year
ORG.11 The primary author year of an organism species shall be specified. Refers to the year in which the first author published the plant/animal name (of any rank)
N/A N alphanumeric
10
Hybrid_species_maternal_organism_id
ORG.12 The identifier of the maternal species constituting the hybrid organism shall be specified based on a controlled vocabulary.
CV [Species]
Y Alphanumeric
12
Hybrid_species_paternal_organism_id
ORG.13 The identifier of the paternal species constituting the hybrid organism shall be specified based on a controlled vocabulary.
CV [Species]
N Alphanumeric
12
Hybrid_type
ORG.14 The hybrid type of an organism shall be defined. EXAMPLE: yes/no
Yes/No
N Boolean
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 364/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Infraspeific_type
ORG.15.CV
The infraspecific type of an organism shall be specified based on a controlled vocabulary.
CV [Infraspecific Type]
N Text 250
Infraspec_descript
ORG.16 The infraspecific description of an organism shall be specified based on a controlled vocabulary. For Influenza Vaccine, the infraspecifc description shall contain the syntax of the antigen in line with the WHO convention. EXAMPLE: A/BRISBANE/59/2007(H1N1)
N/A
N Text 4000
Infraspecific_parenthetical_author
ORG.17 The infraspecific parenthetical author of an organism shall be specified. Refers to the first author, who published the infraspecific plant/animal name (of any rank)
N/A N Text 2000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 365/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Infraspecific_parenthetical_author_year
ORG.18 The infraspecific parenthetical author year of an organism shall be specified. Refers to the year in which the first author published the infraspecific plant/animal name (of any rank)
N/A N alphanumeric
10
Infraspecific_primary_author
ORG.19 The infraspecific primary author of an organism shall be specified. Refers to the first author, who published the infraspecific plant/animal name (of any infraspecific rank)
N/A N Text 2000
Infraspecific_primary_author_year
ORG.20 The infraspecific primary author year of an organism shall be specified. Refers to the year in which the first author published the infraspecific plant/animal name (of any infraspecific rank)
N/A N alphanumeric
10
Modification
MIXT.MOD
The modification section
N This section apply to:
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 366/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
(0..n)
The modification details shall be specified.
-Nucleic Acid -Protein -Polymer -Structurally Diverse Substances -Mixture This section shall be repeatable to describe each modification occurred on each residue modified.
Modification type
MOD.1.CV The type of the modification shall be provided based on a controlled vocabulary. EXAMPLE: Structural
CV [Modification Type]
Y Text 250
Residue modified
MOD.2.CV The name of the residue modified shall be described based on controlled vocabulary. NOTE: For virus or bacteria the value residue modified is = not applicable;
CV [Nucleotide Bases] OR [Amino acid] OR [Substance
Y Text 4000 If Substance_classification_type= protein, the CV [Amino acid] applies; If Substance_classification_type= nucleic acid, the CV [Nucleotide Bases] applies;
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 367/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Name] If Substance_classification_type= polymer, the CV [Substance Name] applies. If Substance_classification_type= Structurally Diverse Substance or Mixture, the value residue modified is= not applicable
Residue_site
MOD.3 The position of specific residue undergone to modifications shall be described. Each residue shall be specified followed by a comma and space. For protein and nucleic acid, the number of the subunit followed by the number of the residue modified shall be specified. The underscore “_” shall be used as separator. EXAMPLE: 1_10 refers to the 10th residue on the 1st subunit Or
N Text 2000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 368/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
A1_10
physical_modification (0..n)
MOD.PM The physical modification section
N This section shall only apply if Modification type= Physical
Role PM.1.CV The role of the physical modification shall be provided based on a controlled vocabulary. EXAMPLE: inactivation, activation
CV [Modification]
Y Text 250
Number_of_parameters
PM.2 The number of parameter that is going to be described as result of the modification shall be provided.
No N Numeric
4 The value is automatically calculated.
Parameter (0..n)
PM.PARA The parameter section N The repeatability of this section is strictly related to the Value of the “Number_of_ Parameter” field. The section shall be repeated as many time as specified in the ‘number_of_parameters’ field.
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 369/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Parameter
PARA.1.CV The parameter shall be described based on controlled vocabulary. EXAMPLE: time, temperature, pressure
CV [Parameter]
Y Text 250
Amount_type
PARA.2.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
amount (0..1)
PARA.AMT The amount section N
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limi AMT.4.CV The prefix of the lower limit unit CV N alpha 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 370/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
t_numerator_unit_prefix
of the substance shall be specified, where available.
[Unit Prefix]
numeric
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 371/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV
The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV
The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV
The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable.
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 372/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: Short, High (temperature)
structural_modification (0..n)
MOD.SM The structural modification section
N This section shall apply if Modification type= Structural This section is repeatable.
Structural_modification_type
SM.1.CV The type of the structural modification shall be described based on a controlled vocabulary
CV [Modification]
Y Text 250
Moiety (0..n)
SM.MOT The moiety section This section describes the moiety affected by the modification where applicable.
N
Moiety_Role
MOT.1.CV The role of the moiety shall be described based on a controlled vocabulary. EXAMPLE: antigen, linker, conjugate
CV [Role]
Y text 250
Moiety_name
MOT.2 The name of the moiety shall be provided.
CV [Substance
Y Text 4000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 373/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
If the substance name is not present in the Controlled Vocabulary, the moiety name shall be described as a free text.
Name]
Moiety_id
MOT.3 The unique identifier assigned to the substance representing the moiety based on controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
CV [Substance Name]
N Alphanumeric
12
Amount_type
MOT.4.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
amount
MOT.AMT The amount section N
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 374/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
(0..1) Quantity
Operator AMT.1.CV CV
[Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_
AMT.7.CV The prefix of the lower limit unit of the substance shall be
CV
N alphanume
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 375/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
denominator_unit_prefix
specified, where available.
[Unit Prefix] ric
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV
The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 376/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV
The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV
The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
molecular fragment (0..n)
SM.MFRAG The molecular fragment section. This section describes the molecular fragment affected by the modification where applicable.
N
Role MFRAG.1.CV
The role of the molecular fragment shall be described based on a controlled vocabulary.
CV [Role]
Y Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 377/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Molecular_fragment_id
MFRAG.2 The unique identifier for molecular fragment shall be provided. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
CV [Substance Name]
N Alphanumeric
12
Molecular_fragment_name
MFRAG.3 The name for molecular fragment shall be specified.
CV [Substance Name]
Y Text 4000
Amount_type
MFRAG.4.CV
The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
amount
MFRAG.AMT
The amount section N
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 378/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
(0..1) Quantity
Operator AMT.1.CV CV
[Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_
AMT.7.CV The prefix of the lower limit unit of the substance shall be
CV
N alphanume
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 379/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
denominator_unit_prefix
specified, where available.
[Unit Prefix] ric
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV
The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 380/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV
The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV
The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
agent_modification (0..n)
MOD.AM The modification agent section. This section described the agent that caused the modification.
N
Agent_modification_type
AM.1.CV The type of the agent used for the modification shall be specified based on a controlled vocabulary. EXAMPLE: chemical, enzymatic
CV [Agent Modification Type]
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 381/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Role AM.2.CV The role of the modification agent shall be specified based on a controlled vocabulary.
CV [Modification]
Y Text 250
Modification_agent
AM.3 The name of modifying agent shall be specified based on a controlled vocabulary.
CV [Substance Name]
Y Text 4000
Modification_agent_id
AM.4 The unique identifier of modifying agent shall be provided. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
CV [Substance Name]
N Alphanumeric
12
Modification_proce
AM.5.CV The modification process shall be specified based on a
CV
N Text
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 382/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
ss controlled vocabulary. EXAMPLE: UV irradiation
[Modification Process]
Amount_type
AM.6.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
amount (0..1)
AM.AMT The amount section N
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 383/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_val
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 384/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
ue
High_limit_ denominator _unit
AMT.12.CV
The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV
The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV
The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 385/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
mixture_constituent (2..n)
MIXT.MXCON
The mixture constituent section The substance constituting the mixture shall be described.
Y The section is mandatory if Substance_type_cv= Mixture
Constituent_id
MXCON.1 The unique identifier assigned to the constituent based on controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
CV [Substance Name]
N Alphanumeric
12
Constituent_name
MXCON.2 The name of the constituent of the mixture shall be described.
CV [Substance Name]
Y Text 4000
Constituent_requirement
MXCON.3.CV
The requirement of the constituent shall be described based on a controlled
CV [Requirement
N Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 386/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
vocabulary. EXAMPLE: may be present
]
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 387/485
4.3.7. SSI for Specified Substance Group 1
For Specified Substance Group 1, the SSI shall be described based on the following data elements:
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
specified_substance_group1
SPCFD.GP1 The specified substance group 1 section The identifying characteristics for the specified substance group 1 shall be specified.
The section is mandatory if Substance_type_cv= Specified_substance_group1
Substance_Classification
COM.2.CV Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture
CV [Substance Class]
Y Text 250
Language
SUB.LANG The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German
CV [Language]
Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology). For the purpose of describing “Language”, “T” shall be used.
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 388/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered synonyms.
Specified_substance_group1_id
GP1.1 The unique identifier assigned to the specified substance group1 shall be specified. NOTE: If a unique “Specified Substance ID” (EVCODE) has been assigned by the EMA, this “Specified Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Specified Substance ID” e. g. for the initial submission of the substance this data element is not required.
N Alphanumeric
12 In the absence of a unique “Specified Substance ID” e.g. for the initial submission of the specified substance this data element shall not be populated. The ID of the substance will be automatically assigned by the system once the message will be processed.
Specified_substance_group1_name
GP1.2 The name of the specified substance group 1 shall be provided in this field. The latest version of the Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.
N/A Y Text 4000
substance_name
COM.SNM The substance name section
Y
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 389/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
(1..n)
This section contains the set of elements for the description of the name of the substance. The latest version of the Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.
Substance_name
SNM.1 The name of the substance shall be specified.
Y Text 4000
Substance_name_type
SNM.2.CV The type of the name shall be specified based on a controlled vocabulary. EXAMPLE: Official name, Code
CV [Substance Name Type]
Y text 250
Language
SNM.3.CV The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German
CV [Language]
Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology).
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 390/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
For the purpose of describing “Language”, “T” shall be used. In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered synonyms.
official_name (0..n)
SNM.ON The official name section N If “Official Name” has been specified in “Substance_Name_Type” this section is mandatory. For any other name type, the section is present as not mandatory.
Official_name_type
ON.1.CV The type of the official name shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Official_name_status
ON.2.CV The status of the code system shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed.
CV [Status]
Y text 250
Official_name_status_chan
ON.3 The change date of the status of the official name shall be specified in line with the ISO 8601 date format, which
ISO 8601 date format
N alphanumeric
10 ISO 8601 advises numeric representation of dates and times on an internationally
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 391/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
ge_date shall be only entered when name is changed. EXAMPLE: 2011-06-01
agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD
official_name_domain (1..n)
ON.DOM Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have at least one “Official Name Domain”.
Official_name_domain
DOM.1.CV The domain of the name shall be provided based on a controlled vocabulary. EXAMPLE: Human Pharmaceutical
CV [Domain]
Y Text 250
official_name_jurisdiction (1..n)
ON.JUR The jurisdiction of the official name section
Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have at least one “Official Name Jurisdiction”.
Official_name_juri
JUR.1.CV The jurisdiction of the official name shall be provided based on ISO 3166-
CV
Y Text 3
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 392/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
sdiction 1 alpha-2 codes with two exceptions: EL (not GR) is used to represent Greece, and UK (not GB) is used to represent the United Kingdom. For the European Union EU shall be used.
[Country Code]
reference_source (1..n)
SNM.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 393/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
substance_code (0..n)
COM.SC The substance code section This section describes the specific code(s) within one or more available code system(s) that apply to a substance.
N
Code SC.1 The specific code (the value) with regard to a referenced code system shall be provided. NOTE: InChI is not considered a code and shall be specified within the structure description.
N/A Y alphanumeric
500
Code_system
SC.2.CV The code system shall be specified based on a controlled vocabulary.
CV [Code System]
Y
Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 394/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Code_system_id
SC.3.CV The identifier for the code system shall be provided based on a controlled vocabulary.
CV [Code System]
N alphanumeric
12
Code_system_status
SC.4.CV The status of the code system shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed.
CV [Status]
Y text 250
Code_system_change_date
SC.5 The change date of the code system shall be specified in line with the ISO 8601 date format, where applicable. EXAMPLE: 2011-06-01
ISO 8601 date format
N alphanumeric
10 This applies only when the code is changed, so it is not applicable for initial submission. ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD
Comment
SC.6 Any comment can be provided in this field, if necessary.
N Text 4000
reference_source (1..n)
SC.RS The reference source section This section describes the reference source information.
Y
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 395/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
For each “Substance Name” a “Reference Source” shall be specified.
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 396/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
version (1..n)
COM.VER The version section This section shall provide information on the version of the substance.
Y Where no “Version Number” and “Effective Date” have been assigned by an authority source, the version number shall be set as 0 with the date set as the date of initial submission of the substance.
Version_number
VER.1 The number of the version of the SSI shall be provided.
N/A Y numeric
4
Effective_date
VER.2 The date when the SSI was effective shall be provided in line with the ISO 8601 date format. This shall be defined when the SSI is generated or modified.
ISO 8601 date format
N alphanumeric
10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 397/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Change_made
VER.3 The description of the updates or changes of the SSI shall be specified. The field will be left empty when first insert of substance.
N/A
N text 4000
reference_information (1..1)
COM.RI The reference information section This section is used to provide details about: - substance classification - target - gene from which proteins are derived - substance relationship
Y
Comment
RI.1 Any comment can be provided in this field, if necessary.
N Text 4000
substance_classification (1..n)
RI.SCLF The substance classification
Y One or more “Substance Classifications” shall be specified.
Domain SCLF.1.CV The domain of the substance classification shall be provided based on a controlled vocabulary. EXAMPLE: Human Pharmaceuticals
CV [Domain]
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 398/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Substance_Classification
SCLF.2.CV Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture
CV [Substance Class]
Y Text 250 The information provided in this field shall be automatically populated based on the information provided in the Substance_Classification field (COM.2.CV).
Substance_classification_type
SCLF.3.CV The type of the substance shall be provided based on a controlled vocabulary. NOTE: When Substance_Classification=mixture and the substances that are forming the mixture are of the same class, the class of those substances shall be specified in this field. EXAMPLE: two chemicals forming the mixture, specified_classification_type = chemical If the substances that are forming the mixture are of a different class, the value ‘mixture’ shall be specified in this field. EXAMPLE: One polymer combined in a protein, Specified_classification_type =mixture
CV [Substance Type] [Specified substance Type]
Y Text 250 When Substance_Classification= Single or mixture, the [Substance Type] CV applies. When Substance_Classification=Specified substance the [Specified Substance Type] CV applies.
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 399/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Substance_classification_code
SCLF.4 The code of the classification type where applicable shall be specified based on a controlled vocabulary.
N alphanumeric
250
subtype (1..n)
SCLF.ST The subtype section Y
Substance_class_subtype
ST.1.CV The sub-type of the classification shall be described based on a controlled vocabulary. EXAMPLE: Vaccine, Herbal, Multiple Substances
CV [Substance subtype]
Y Text 250
reference_source (1..n)
SCLF.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 400/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
substance_relationship (0..n)
RI.REL The substance relationship This section shall provide information related to relationship of a substance, where this is applicable.
N
Relationship
REL.1.CV The relationship of a substance shall be defined based on a controlled vocabulary. NOTE: Target and gene elements are not to be specified in this section.
CV [relationship type]
Y Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 401/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: transporter, metabolic enzyme
Interaction_type
REL.2.CV The type of interaction shall be specified based on a controlled vocabulary, where applicable. EXAMPLE: covalent
CV [Interaction Type]
N Text 250
Substance_id
REL.3 The substance identifier, for which the relationship is specified, shall be described. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
CV [Substance Name]
N Alphanumeric
12
Substance_name
REL.4 The substance name shall be specified.
CV [Substance Name]
Y text 4000 Mandatory when there is a “substance relationship”
Amount_type
REL.5.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 402/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
amount (0..1)
REL.AMT The amount section N
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limi AMT.7.CV The prefix of the lower limit unit of CV N alpha 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 403/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
t_ denominator_unit_prefix
the substance shall be specified, where available.
[Unit Prefix]
numeric
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average AMT.14 The average amount or single value N Nume 10
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 404/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
of the substance shall be specified.
ric
Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
reference_source (1..n)
REL.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary.
CV [Source]
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 405/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: INN
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
N text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
gene (0..n)
RI.GN The gene section This section shall provide a description of the gene in relation to a substance, where applicable. The gene section refers only to gene that is the origin of the substance (protein).
N This section does not apply when Substance_classification_type is equal to chemical, Specified Substance Group 1, Specified Substance Group 2 and Specified substance group 3.
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 406/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Gene_sequence_origin
GN.1.CV The common name for the organism from which the final gene sequence originated shall be specified based on a controlled vocabulary. NOTE: it applies primarily to proteins.
CV [Organism Name]
N Text 2000
Gene_id GN.2 The identifier of the gene shall be provided based on a controlled vocabulary. E.g.: YP_299723.1
CV [Gene Name]
N alphanumeric
12
Gene_name
GN.3 The complete name given for a gene shall be provided based on a controlled vocabulary. E.g.: hIL-10 gene
CV [Gene Name]
Y Text 4000
reference_source (1..n)
GN.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source
RS.2.CV The type of the reference source shall be specified based on a controlled
CV
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 407/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
_type vocabulary. EXAMPLE: INN
[Source]
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
Gene_element (0..n)
RI.GE The gene element section N
Gene_element_type
GE.1.CV The type of the gene element shall be specified based on a controlled vocabulary.
CV [Gene Element
Y Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 408/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: enhancer, promoter, silencer, terminator
Type]
Gene_element_id
GE.2 The unique identifier for the gene element shall be specified based on a controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
CV [Substance Name]
N Alphanumeric
12
Gene_element_name
GE.3 The specific gene element name shall be described based on a controlled vocabulary.
CV [Substance Name]
Y Text 4000
reference_source (1..n)
GE.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not.
Yes /No
Y Boolean
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 409/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Yes or No values apply.
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
Target (0..n)
RI.TRG The target section This section shall provide information on the target substance.
N This section does not apply when Substance_classification_type is equal to Specified Substance
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 410/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
It refers for genes to the target of the protein expressed by that gene. For all the other substances type it refers to the substrate of the substance. EXAMPLE: enzyme, protein/channel, receptor
Group 1, Specified Substance Group 2 and Specified substance group 3.
Target_gene_id
TRG.1 The identifier of the target gene shall be provided.
CV [Target Gene]
N alphanumeric
12
Target_gene_name
TRG.2 The target gene name shall be specified based on a controlled vocabulary. EXAMPLE: single substance, an enzyme type
CV [Target Gene]
Y Text 4000
Interaction_type
TRG.3.CV The type of interaction shall be specified based on a controlled vocabulary. EXAMPLE: Inhibition
CV [Target interaction type]
Y text 250
Target_organism_type
TRG.4.CV The type of target organism shall be specified based on a controlled vocabulary. EXAMPLE: human, viral
CV [Organism type]
N Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 411/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Target_type
TRG.5.CV The target type shall be specified based on a controlled vocabulary. EXAMPLE: enzyme, receptor, membrane
CV [Target type]
N Text 250
reference_source (1..n)
TRG.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 412/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
constituent (1..n)
GP1.CON The constituent section The identifying characteristics of the constituent of the specified substance group 1 shall be specified. The section is repeatable to allow the description of: - the parent ID(s) of the specified substance group 1 that is always referring to Substance ID(s) - All the components of substances such as impurities, degradent, metabolite, active markers and solvent used in herbal preparations. NOTE: the constituent section shall be repeatable to describe multiple substances where each of the applicable parent IDs shall be
Y The section is mandatory if Substance_type_cv= Specified_substance_group1 It is mandatory to specify at least one constituent section with role = parent ID;
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 413/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
provided.
Substance_id
CON.1 The unique identifier assigned to the substance that constitutes the specified substance group 1 shall be defined based on controlled vocabulary. For herbals, the constituents refers to herbal markers or the herbal substance (s) which is present in the herbal preparation (e.g. Sennosides A; Senna Acutifolia et Senna Angustifolia leaf tincture) For vaccines, the constituents refer to adjuvant (s). For multiple substances, the constituent refers to the substances complexed together to form the final multiple substance (e.g. Insulin human and protamine are constituents of the Insulin Isophane) NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial
CV [Substance Name]
N Alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 414/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
submission of the substance this data element is not required.
Substance_name
CON.2 The name of the substance which is the constituent of the specified substance group 1 shall be described.
CV [Substance Name]
Y Text 4000
Substance_role
CON.3.CV The role of the substance in the specified substance shall be described based on a controlled vocabulary. An impurity component is not described in the Specified Substance Group 1. The parent ID of a specified substance group 1 shall always be specified. EXAMPLE: active marker, component, degradent, metabolite, active moiety
CV [Constituent Role]
Y Text 250 The constituent section shall be present as mandatory with a role=Parent ID
Amount_type
CON.4.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
amount (0..1)
CON.AMT The amount section N
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 415/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limi AMT.8 The higher limit value of the N Nume 10
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 416/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
t_numerator_value
substance shall be specified, where available.
ric
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.
CV [Unit
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 417/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
Prefix]
Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
Property (0..n)
GP1.PROP The property section The characteristics of the property shall be described.
N
Property_type
PROP.1.CV The type of property shall be specified based on a controlled vocabulary. EXAMPLE: physical, chemical, enzymatic, immunological
CV [Property Type]
Y Text 250
Property_name
PROP.2.CV The name of property shall be specified based on a Controlled Vocabulary.
CV [Parameter]
Y Text 250
Substance_id
PROP.3 The identifier of the substance related to a defining property shall be described where applicable and based on controlled vocabulary.
CV [Substance Name]
N Alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 418/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: solubility in Water, Water ID shall be specified NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
Substance_name
PROP.4 The name of the substance related to a defining property shall be described where applicable. EXAMPLE: solubility in Water, Water shall be specified
CV [Substance Name]
N Text 4000
Amount_type
PROP.5.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
amount (1..1)
PROP.AMT The amount section Y
Quantity Operator
AMT.1.CV CV
N text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 419/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
[Quantity Operator]
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 420/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV The applicable unit for the average shall be specified based on a
CV
N alphanume
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 421/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
controlled vocabulary.
[Unit of Measure]
ric
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
physical_form (0..n)
GP1.PF The physical form section The characteristics of the physical form of the specified substance shall be described. It is required to provide the physical form information when applicable.
N
Physical_state
PF.1.CV The physical form shall be specified based on a controlled vocabulary. EXAMPLE: solid, liquid
CV [Physical state]
Y Text 250 If a physical_form of the specified substance is applicable, the “physical_state” should be specified.
Physical_form_type
PF.2.CV The physical form type shall be specified based on a controlled vocabulary. EXAMPLE: crystaline, amorphous, tincture, dry, extract
CV [Physical Form]
Y Text 250
Amount_type
PF.3.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 422/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
amount (0..1)
PF.AMT The amount section N
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limi AMT.7.CV The prefix of the lower limit unit of CV N alpha 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 423/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
t_ denominator_unit_prefix
the substance shall be specified, where available.
[Unit Prefix]
numeric
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average AMT.14 The average amount or single value N Nume 10
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 424/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
of the substance shall be specified.
ric
Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
reference_source (0..n)
GP1.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary.
CV [Source]
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 425/485
SSI level Data Element Name
Ref Code Data Element Description and Notes
CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: INN
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 426/485
4.3.8. SSI for Specified Substance Group 2
For Specified Substance Group 2, the SSI shall be described based on the following data elements:
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
specified_substance_group2
SPCFD.GP2
The specified substance group 2 section The identifying characteristics for the specified substance group 2 shall be specified.
The section is mandatory if Substance_type_cv= Specified_substance_group2
Substance_Classification
COM.2.CV Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture
CV [Substance Class]
Y Text 250
Language
SUB.LANG The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German
CV [Language]
Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology). For the purpose of describing “Language”, “T” shall be
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 427/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
used. In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered synonyms.
Specified_substance_group2_id
GP2.1 The unique identifier assigned to the specified substance group2 shall be specified. NOTE: If a unique “Specified Substance ID” (EVCODE) has been assigned by the EMA, this “Specified Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Specified Substance ID” e. g. for the initial submission of the substance this data element is not required.
N Alphanumeric
12
Specified_substance_group2_name
GP2.2 The name of the specified substance group 2 shall be described. The latest version of the Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.
N/A Y Text 4000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 428/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
Parent_substance_id
GP2.3 The unique identifier assigned to the substance that is the parent of the specified substance shall be provided based on controlled vocabulary. The ID of the parent for the specified substance group 1 may refer to either a substance ID or a specified substance group 1 ID. NOTE: If a unique “ID” (EVCODE) has been assigned by the EMA, this “ID” shall be specified based on the Substance Name CV. In the absence of a unique “ID” e. g. for the initial submission of specified substance and parent substance, the name of the parent substance shall be specified.
CV [Substance Name]
Y Alphanumeric
4000
substance_name (1..n)
COM.SNM The substance name section This section contains the set of elements for the description of the name of the substance. The latest version of the Naming Conventions document (Ref. Doc.:
Y
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 429/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
EMA/720247/2011) shall be followed.
Substance_name
SNM.1 The name of the substance shall be specified.
Y Text 4000
Substance_name_type
SNM.2.CV The type of the name shall be specified based on a controlled vocabulary. EXAMPLE: Official name, Code
CV [Substance Name Type]
Y text 250
Language
SNM.3.CV The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German
CV [Language]
Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology). For the purpose of describing “Language”, “T” shall be used. In all other cases there is
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 430/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered synonyms.
official_name (0..n)
SNM.ON The official name section N If “Official Name” has been specified in “Substance_Name_Type” this section is mandatory. For any other name type, the section is present as not mandatory.
Official_name_type
ON.1.CV The type of the official name shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Official_name_status
ON.2.CV The status of the code system shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed.
CV [Status]
Y text 250
Official_name_status_change_date
ON.3 The change date of the status of the official name shall be specified in line with the ISO 8601 date format, which shall be only entered when name is changed.
ISO 8601 date format
N alphanumeric
10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis.
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 431/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: 2011-06-01
It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD
official_name_domain (1..n)
ON.DOM Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have at least one “Official Name Domain”.
Official_name_domain
DOM.1.CV The domain of the name shall be provided based on a controlled vocabulary. EXAMPLE: Human Pharmaceutical
CV [Domain]
Y Text 250
official_name_jurisdiction (1..n)
ON.JUR The jurisdiction of the official name section
Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have at least one “Official Name Jurisdiction”.
Official_name_juri
JUR.1.CV The jurisdiction of the official name shall be provided based on ISO 3166-1
CV
Y Text 3
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 432/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
sdiction alpha-2 codes with two exceptions: EL (not GR) is used to represent Greece, and UK (not GB) is used to represent the United Kingdom. For the European Union EU shall be used.
[Country Code]
reference_source (1..n)
SNM.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 433/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
substance_code (0..n)
COM.SC The substance code section This section describes the specific code(s) within one or more available code system(s) that apply to a substance.
N
Code SC.1 The specific code (the value) with regard to a referenced code system shall be provided. NOTE: InChI is not considered a code and shall be specified within the structure description.
N/A Y alphanumeric
500
Code_system
SC.2.CV The code system shall be specified based on a controlled vocabulary.
CV
Y
Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 434/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
[Code System]
Code_system_id
SC.3.CV The identifier for the code system shall be provided based on a controlled vocabulary.
CV [Code System]
N alphanumeric
12
Code_system_status
SC.4.CV The status of the code system shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed.
CV [Status]
Y text 250
Code_system_change_date
SC.5 The change date of the code system shall be specified in line with the ISO 8601 date format, where applicable. EXAMPLE: 2011-06-01
ISO 8601 date format
N alphanumeric
10 This applies only when the code is changed, so it is not applicable for initial submission. ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD
Commen SC.6 Any comment can be provided in this N Text 4000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 435/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
t field, if necessary.
reference_source (1..n)
SC.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 436/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
version (1..n)
COM.VER The version section This section shall provide information on the version of the substance.
Y Where no “Version Number” and “Effective Date” have been assigned by an authority source, the version number shall be set as 0 with the date set as the date of initial submission of the substance.
Version_number
VER.1 The number of the version of the SSI shall be provided.
N/A Y numeric
4
Effective_date
VER.2 The date when the SSI was effective shall be provided in line with the ISO 8601 date format. This shall be defined when the SSI is generated or modified.
ISO 8601 date format
N alphanumeric
10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 437/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
element: e.g. year-month-day YYYY-MM-DD
Change_made
VER.3 The description of the updates or changes of the SSI shall be specified. The field will be left empty when first insert of substance.
N/A
N text 4000
reference_information (1..1)
COM.RI The reference information section This section is used to provide details about: - substance classification - target - gene from which proteins are derived - substance relationship
Y
Comment
RI.1 Any comment can be provided in this field, if necessary.
N Text 4000
substance_classification (1..n)
RI.SCLF The substance classification
Y One or more “Substance Classifications” shall be specified.
Domain SCLF.1.CV The domain of the substance classification shall be provided based on a controlled vocabulary. EXAMPLE: Human Pharmaceuticals
CV [Domain]
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 438/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
Substance_Classification
SCLF.2.CV Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture
CV [Substance Class]
Y Text 250 The information provided in this field shall be automatically populated based on the information provided in the Substance_Classification field (COM.2.CV).
Substance_classification_type
SCLF.3.CV The type of the substance shall be provided based on a controlled vocabulary. NOTE: When Substance_Classification=mixture and the substances that are forming the mixture are of the same class, the class of those substances shall be specified in this field. EXAMPLE: two chemicals forming the mixture, specified_classification_type = chemical If the substances that are forming the mixture are of a different class, the value ‘mixture’ shall be specified in this field. EXAMPLE: One polymer combined in a
CV [Substance Type] [Specified substance Type]
Y Text 250 When Substance_Classification= Single or mixture, the [Substance Type] CV applies. When Substance_Classification=Specified substance the [Specified Substance Type] CV applies.
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 439/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
protein, Specified_classification_type =mixture
Substance_classification_code
SCLF.4 The code of the classification type where applicable shall be specified based on a controlled vocabulary.
N alphanumeric
250
subtype (1..n)
SCLF.ST The subtype section Y
Substance_class_subtype
ST.1.CV The sub-type of the classification shall be described based on a controlled vocabulary. EXAMPLE: Vaccine, Herbal, Multiple Substances
CV [Substance subtype]
Y Text 250
reference_source (1..n)
SCLF.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source
RS.2.CV The type of the reference source shall be specified based on a controlled
CV
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 440/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
_type vocabulary. EXAMPLE: INN
[Source]
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
substance_relationship (0..n)
RI.REL The substance relationship This section shall provide information related to relationship of a substance, where this is applicable.
N
Relationship
REL.1.CV The relationship of a substance shall be defined based on a controlled
CV
Y Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 441/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
vocabulary. NOTE: Target and gene elements are not to be specified in this section. EXAMPLE: transporter, metabolic enzyme
[relationship type]
Interaction_type
REL.2.CV The type of interaction shall be specified based on a controlled vocabulary, where applicable. EXAMPLE: covalent
CV [Interaction Type]
N Text 250
Substance_id
REL.3 The substance identifier, for which the relationship is specified, shall be described. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
CV [Substance Name]
N Alphanumeric
12
Substance_name
REL.4 The substance name shall be specified.
CV
Y text 4000 Mandatory when there is a “substance relationship”
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 442/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
[Substance Name]
Amount_type
REL.5.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
amount (0..1)
REL.AMT The amount section N
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_numerator_unit_prefix
AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Low_limit_denominator_val
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 443/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
ue
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_
AMT.12.CV The higher limit unit of the substance shall be specified, where available.
CV
N alphanume
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 444/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
denominator _unit
[Unit of Measure]
ric
High_limit_ denominator_unit_prefix
AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
reference_source (1..n)
REL.RS The reference source section This section describes the reference source information. For each “Substance Name” a
Y
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 445/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
“Reference Source” shall be specified.
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 446/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
gene (0..n)
RI.GN The gene section This section shall provide a description of the gene in relation to a substance, where applicable. The gene section refers only to gene that is the origin of the substance (protein).
N This section does not apply when Substance_classification_type is equal to chemical, Specified Substance Group 1, Specified Substance Group 2 and Specified substance group 3.
Gene_sequence_origin
GN.1.CV The common name for the organism from which the final gene sequence originated shall be specified based on a controlled vocabulary. NOTE: it applies primarily to proteins.
CV [Organism Name]
N Text 2000
Gene_id GN.2 The identifier of the gene shall be provided based on a controlled vocabulary. E.g.: YP_299723.1
CV [Gene Name]
N alphanumeric
12
Gene_name
GN.3 The complete name given for a gene shall be provided based on a controlled vocabulary. E.g.: hIL-10 gene
CV [Gene Name]
Y Text 4000
reference_source
GN.RS The reference source section This section describes the reference
Y
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 447/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
(1..n) source information. For each “Substance Name” a “Reference Source” shall be specified.
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34
N/A N text 2500
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 448/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
Literature reference: Encycl. 3: 429 (1792)
Gene_element (0..n)
RI.GE The gene element section N
Gene_element_type
GE.1.CV The type of the gene element shall be specified based on a controlled vocabulary. EXAMPLE: enhancer, promoter, silencer, terminator
CV [Gene Element Type]
Y Text 250
Gene_element_id
GE.2 The unique identifier for the gene element shall be specified based on a controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
CV [Substance Name]
N Alphanumeric
12
Gene_element_na
GE.3 The specific gene element name shall be described based on a controlled
CV
Y Text 4000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 449/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
me vocabulary.
[Substance Name]
reference_source (1..n)
GE.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 450/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
Target (0..n)
RI.TRG The target section This section shall provide information on the target substance. It refers for genes to the target of the protein expressed by that gene. For all the other substances type it refers to the substrate of the substance. EXAMPLE: enzyme, protein/channel, receptor
N This section does not apply when Substance_classification_type is equal to Specified Substance Group 1, Specified Substance Group 2 and Specified substance group 3.
Target_gene_id
TRG.1 The identifier of the target gene shall be provided.
CV [Target Gene]
N alphanumeric
12
Target_gene_name
TRG.2 The target gene name shall be specified based on a controlled vocabulary.
CV [Target
Y Text 4000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 451/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: single substance, an enzyme type
Gene]
Interaction_type
TRG.3.CV The type of interaction shall be specified based on a controlled vocabulary. EXAMPLE: Inhibition
CV [Target interaction type]
Y text 250
Target_organism_type
TRG.4.CV The type of target organism shall be specified based on a controlled vocabulary. EXAMPLE: human, viral
CV [Organism type]
N Text 250
Target_type
TRG.5.CV The target type shall be specified based on a controlled vocabulary. EXAMPLE: enzyme, receptor, membrane
CV [Target type]
N Text 250
reference_source (1..n)
TRG.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 452/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
Manufacturing (1..1)
GP2.MANU The manufacturing section The main characteristics in relation to the manufacturing of the substance shall be specified.
Y The section is mandatory if Substance_type_cv= Specified_substance_group2
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 453/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
Manufacturer_id
MANU.1 The unique code used to track manufacturers shall be provided.
N/A Y Alphanumeric
12
Manufacturer_name
MANU.2.CV
The name of the manufacturer of the specified substance shall be provided.
CV [Manufacturer Name]
Y Text 2000
Manufacturing_type
MANU.3.CV
The type of the manufacturer shall be provided based on a controlled vocabulary.
CV [Manufacturing Type]
Y Text 250
Production_method_type
MANU.4.CV
The type of the production method shall be provided based on a controlled vocabulary. EXAMPLE: synthetic, extractive, semisynthetic, biosynthetic, etc
CV [Production Method] Or [Herbal Production Method]
Y Text 250 When Substance_class_subtype= Herbal, the [Herbal Production Method] CV applies. For all the other subtype, [Production Method] CV applies.
Production_system_type
MANU.5.CV
The type of the production system shall be provided based on a controlled vocabulary. EXAMPLE: cell line, animal, tissue, egg
CV [Production System Type]
Y Text 250
Production_syste
MANU.6.CV
The production system description shall be provided when available.
CV
N Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 454/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
m EXAMPLE: cho cell, goat, bovine lungs The production system does not apply to Herbals.
[Production System]
reference_source (1..n)
MANU.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 455/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
4.3.9. SSI for Specified Substance Group 3
For Specified Substance Group 3, the SSI shall be described based on the following data elements:
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
specified_substance_group3
SPCFD.GP3
The specified substance group 3 section The identifying characteristics of the specified substance group 3 shall be provided.
The section is mandatory if Substance_type_cv= Specified_substance_group3
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 456/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
Substance_Classification
COM.2.CV Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture
CV [Substance Class]
Y Text 250
Language
SUB.LANG
The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German
CV [Language]
Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology). For the purpose of describing “Language”, “T” shall be used. In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered synonyms.
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 457/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
Specified_substance_group3_id
GP3.1 The unique identifier assigned to the specified substance group2 shall be specified. NOTE: If a unique “Specified Substance ID” (EVCODE) has been assigned by the EMA, this “Specified Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Specified Substance ID” e. g. for the initial submission of the substance this data element is not required.
N Alphanumeric
12
Specified_substance_group3_name
GP3.2 The name of the specified substance group 3 shall be described. The latest version of the Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.
N/A
Y Text 4000
Parent_substance_id
GP3.3 The unique identifier assigned to the substance that is the parent of the specified substance shall be provided based on controlled vocabulary. The ID of the parent for the specified substance group 3 may refer to either a substance ID or specified substance
CV [Substance Name]
Y Alphanumeric
4000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 458/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
group 1 ID. NOTE: If a unique “ID” (EVCODE) has been assigned by the EMA, this “ID” shall be specified based on the Substance Name CV. In the absence of a unique “ID” e. g. for the initial submission of specified substance and parent substance, the name of the parent substance shall be specified.
substance_name (1..n)
COM.SNM The substance name section This section contains the set of elements for the description of the name of the substance. The latest version of the Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.
Y
Substance_name
SNM.1 The name of the substance shall be specified.
Y Text 4000
Substance_name_type
SNM.2.CV The type of the name shall be specified based on a controlled vocabulary.
CV [Substance
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 459/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: Official name, Code
Name Type]
Language
SNM.3.CV The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German
CV [Language]
Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology). For the purpose of describing “Language”, “T” shall be used. In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered synonyms.
official_name
SNM.ON The official name section N If “Official Name” has been specified in “Substance_Name_Type” this
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 460/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
(0..n) section is mandatory. For any other name type, the section is present as not mandatory.
Official_name_type
ON.1.CV The type of the official name shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Official_name_status
ON.2.CV The status of the code system shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed.
CV [Status]
Y text 250
Official_name_status_change_date
ON.3 The change date of the status of the official name shall be specified in line with the ISO 8601 date format, which shall be only entered when name is changed. EXAMPLE: 2011-06-01
ISO 8601 date format
N alphanumeric
10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD
official_name_domai
ON.DOM Y If “Official Name” has been specified in “Substance Name
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 461/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
n (1..n)
Type” this section is mandatory. Each “Official Name” shall have at least one “Official Name Domain”.
Official_name_domain
DOM.1.CV The domain of the name shall be provided based on a controlled vocabulary. EXAMPLE: Human Pharmaceutical
CV [Domain]
Y Text 250
official_name_jurisdiction (1..n)
ON.JUR The jurisdiction of the official name section
Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have at least one “Official Name Jurisdiction”.
Official_name_jurisdiction
JUR.1.CV The jurisdiction of the official name shall be provided based on ISO 3166-1 alpha-2 codes with two exceptions: EL (not GR) is used to represent Greece, and UK (not GB) is used to represent the United Kingdom. For the European Union EU shall be used.
CV [Country Code]
Y Text 3
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 462/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
reference_source (1..n)
SNM.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 463/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
substance_code (0..n)
COM.SC The substance code section This section describes the specific code(s) within one or more available code system(s) that apply to a substance.
N
Code SC.1 The specific code (the value) with regard to a referenced code system shall be provided. NOTE: InChI is not considered a code and shall be specified within the structure description.
N/A Y alphanumeric
500
Code_system
SC.2.CV The code system shall be specified based on a controlled vocabulary.
CV [Code System]
Y
Text 250
Code_sys SC.3.CV The identifier for the code system shall CV N alpha 12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 464/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
tem_id be provided based on a controlled vocabulary.
[Code System]
numeric
Code_system_status
SC.4.CV The status of the code system shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed.
CV [Status]
Y text 250
Code_system_change_date
SC.5 The change date of the code system shall be specified in line with the ISO 8601 date format, where applicable. EXAMPLE: 2011-06-01
ISO 8601 date format
N alphanumeric
10 This applies only when the code is changed, so it is not applicable for initial submission. ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD
Comment
SC.6 Any comment can be provided in this field, if necessary.
N Text 4000
reference_ SC.RS The reference source section Y
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 465/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
source (1..n)
This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 466/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
version (1..n)
COM.VER The version section This section shall provide information on the version of the substance.
Y Where no “Version Number” and “Effective Date” have been assigned by an authority source, the version number shall be set as 0 with the date set as the date of initial submission of the substance.
Version_number
VER.1 The number of the version of the SSI shall be provided.
N/A Y numeric
4
Effective_date
VER.2 The date when the SSI was effective shall be provided in line with the ISO 8601 date format. This shall be defined when the SSI is generated or modified.
ISO 8601 date format
N alphanumeric
10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 467/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
the largest to the smallest element: e.g. year-month-day YYYY-MM-DD
Change_made
VER.3 The description of the updates or changes of the SSI shall be specified. The field will be left empty when first insert of substance.
N/A
N text 4000
reference_information (1..1)
COM.RI The reference information section This section is used to provide details about: - substance classification - target - gene from which proteins are derived - substance relationship
Y
Comment
RI.1 Any comment can be provided in this field, if necessary.
N Text 4000
substance_classification (1..n)
RI.SCLF The substance classification
Y One or more “Substance Classifications” shall be specified.
Domain SCLF.1.CV
The domain of the substance classification shall be provided based on a controlled vocabulary.
CV [Domain]
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 468/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: Human Pharmaceuticals
Substance_Classification
SCLF.2.CV
Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture
CV [Substance Class]
Y Text 250 The information provided in this field shall be automatically populated based on the information provided in the Substance_Classification field (COM.2.CV).
Substance_classification_type
SCLF.3.CV
The type of the substance shall be provided based on a controlled vocabulary. NOTE: When Substance_Classification=mixture and the substances that are forming the mixture are of the same class, the class of those substances shall be specified in this field. EXAMPLE: two chemicals forming the mixture, specified_classification_type = chemical If the substances that are forming the mixture are of a different class, the value ‘mixture’ shall be specified in this field.
CV [Substance Type] [Specified substance Type]
Y Text 250 When Substance_Classification= Single or mixture, the [Substance Type] CV applies. When Substance_Classification=Specified substance the [Specified Substance Type] CV applies.
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 469/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: One polymer combined in a protein, Specified_classification_type =mixture
Substance_classification_code
SCLF.4 The code of the classification type where applicable shall be specified based on a controlled vocabulary.
N alphanumeric
250
subtype (1..n)
SCLF.ST The subtype section Y
Substance_class_subtype
ST.1.CV The sub-type of the classification shall be described based on a controlled vocabulary. EXAMPLE: Vaccine, Herbal, Multiple Substances
CV [Substance subtype]
Y Text 250
reference_source (1..n)
SCLF.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 470/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
substance_relationship
RI.REL The substance relationship This section shall provide information related to relationship of a substance,
N
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 471/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
(0..n)
where this is applicable.
Relationship
REL.1.CV The relationship of a substance shall be defined based on a controlled vocabulary. NOTE: Target and gene elements are not to be specified in this section. EXAMPLE: transporter, metabolic enzyme
CV [relationship type]
Y Text 250
Interaction_type
REL.2.CV The type of interaction shall be specified based on a controlled vocabulary, where applicable. EXAMPLE: covalent
CV [Interaction Type]
N Text 250
Substance_id
REL.3 The substance identifier, for which the relationship is specified, shall be described. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not
CV [Substance Name]
N Alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 472/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
required.
Substance_name
REL.4 The substance name shall be specified.
CV [Substance Name]
Y text 4000 Mandatory when there is a “substance relationship”
Amount_type
REL.5.CV The type of the amount of the substance shall be specified using a controlled vocabulary.
CV [Amount Type]
N Text 250
amount (0..1)
REL.AMT The amount section N
Quantity Operator
AMT.1.CV CV [Quantity Operator]
N text 250
Low_limit_numerator_value
AMT.2 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_numerator_unit
AMT.3.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limi AMT.4.CV The prefix of the lower limit unit of the CV N alpha 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 473/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
t_numerator_unit_prefix
substance shall be specified, where available.
[Unit Prefix]
numeric
Low_limit_denominator_value
AMT.5 The lower limit value of the substance shall be specified, where available.
N Numeric
10
Low_limit_ denominator _unit
AMT.6.CV The lower limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
Low_limit_ denominator_unit_prefix
AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
High_limit_numerator_value
AMT.8 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_numerator_unit
AMT.9.CV The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_numerator_unit_prefix
AMT.10.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 474/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
High_limit_denominator_value
AMT.11 The higher limit value of the substance shall be specified, where available.
N Numeric
10
High_limit_ denominator _unit
AMT.12.CV
The higher limit unit of the substance shall be specified, where available.
CV [Unit of Measure]
N alphanumeric
250
High_limit_ denominator_unit_prefix
AMT.13.CV
The prefix of the higher limit unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Average
AMT.14 The average amount or single value of the substance shall be specified.
N Numeric
10
Prefix AMT.15.CV
The prefix of the average unit of the substance shall be specified, where available.
CV [Unit Prefix]
N alphanumeric
250
Unit AMT.16.CV
The applicable unit for the average shall be specified based on a controlled vocabulary.
CV [Unit of Measure]
N alphanumeric
250
Non_numeric_value
AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)
N alphanumeric
250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 475/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
reference_source (1..n)
REL.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 476/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
gene (0..n)
RI.GN The gene section This section shall provide a description of the gene in relation to a substance, where applicable. The gene section refers only to gene that is the origin of the substance (protein).
N This section does not apply when Substance_classification_type is equal to chemical, Specified Substance Group 1, Specified Substance Group 2 and Specified substance group 3.
Gene_sequence_origin
GN.1.CV The common name for the organism from which the final gene sequence originated shall be specified based on a controlled vocabulary. NOTE: it applies primarily to proteins.
CV [Organism Name]
N Text 2000
Gene_id GN.2 The identifier of the gene shall be provided based on a controlled vocabulary. E.g.: YP_299723.1
CV [Gene Name]
N alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 477/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
Gene_name
GN.3 The complete name given for a gene shall be provided based on a controlled vocabulary. E.g.: hIL-10 gene
CV [Gene Name]
Y Text 4000
reference_source (1..n)
GN.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 478/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
Gene_element (0..n)
RI.GE The gene element section N
Gene_element_type
GE.1.CV The type of the gene element shall be specified based on a controlled vocabulary. EXAMPLE: enhancer, promoter, silencer, terminator
CV [Gene Element Type]
Y Text 250
Gene_element_id
GE.2 The unique identifier for the gene element shall be specified based on a controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE)
CV [Substance Name]
N Alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 479/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.
Gene_element_name
GE.3 The specific gene element name shall be described based on a controlled vocabulary.
CV [Substance Name]
Y Text 4000
reference_source (1..n)
GE.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary.
CV [Source]
Y text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 480/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: INN
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
Target (0..n)
RI.TRG The target section This section shall provide information on the target substance. It refers for genes to the target of the protein expressed by that gene. For all the other substances type it refers
N This section does not apply when Substance_classification_type is equal to Specified Substance Group 1, Specified Substance Group 2 and Specified substance group 3.
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 481/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
to the substrate of the substance. EXAMPLE: enzyme, protein/channel, receptor
Target_gene_id
TRG.1 The identifier of the target gene shall be provided.
CV [Target Gene]
N alphanumeric
12
Target_gene_name
TRG.2 The target gene name shall be specified based on a controlled vocabulary. EXAMPLE: single substance, an enzyme type
CV [Target Gene]
Y Text 4000
Interaction_type
TRG.3.CV The type of interaction shall be specified based on a controlled vocabulary. EXAMPLE: Inhibition
CV [Target interaction type]
Y text 250
Target_organism_type
TRG.4.CV The type of target organism shall be specified based on a controlled vocabulary. EXAMPLE: human, viral
CV [Organism type]
N Text 250
Target_type
TRG.5.CV The target type shall be specified based on a controlled vocabulary.
CV [Target
N Text 250
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 482/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
EXAMPLE: enzyme, receptor, membrane type]
reference_source (1..n)
TRG.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 483/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500
Grade (1..1)
GP3.GRD The grade section The characteristics of the grade of the substance shall be specified.
Y The section is mandatory if Substance_type_cv= Specified_substance_group3
Grade_type
GRD.1.CV The type of the grade shall be provided based on a controlled vocabulary.
CV [Grade Type]
Y Text
250
Grade_name
GRD.2 The name of the grade as specified in the monograph shall be provided. EXAMPLE: purified water, water for injection, Insulin Human Injection
N/A Y Text 4000
Grade_reference_source
GRD.3 The specific reference to a monograph source shall be provided. EXAMPLE: For Insulin zinc injectable suspension (crystalline) monograph. Ph. Eu. Ed 7th
N/A
Y Text
4000
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 484/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
2011 (7.2)
reference_source (1..n)
GRD.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.
Y
Public_domain
RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.
Yes /No
Y Boolean
Reference_source_type
RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN
CV [Source]
Y text 250
Reference_source_class
RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission
CV [Source Class]
Y text 250
Reference_source_id
RS.4 The code or number referring to the reference source shall be specified.
N/A N alphanumeric
12
Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004
EMA/721630/2011 Page 485/485
SSI level Data Element Name
Ref Code Data Element Description and Notes CV Reference
Mandatory
Type Field Length
Business Rules
Reference_source_citation
RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)
N/A N text 2500